TruBridge (TBRG) 10-K 18 Mar 19 2018 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 11, 2019	Jun. 30, 2018
Document Information and Entity Information [Abstract]
Entity Registrant Name	COMPUTER PROGRAMS & SYSTEMS INC
Entity Central Index Key	0001169445
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Emerging Growth Company	false
Entity Small Business Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		14,335,180
Trading Symbol	CPSI
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 330,156,830

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 5,732	$ 520
Accounts receivable, net of allowance for doubtful accounts of $2,124 and $2,654, respectively	40,474	38,061
Financing receivables, current portion, net	15,059	15,055
Inventories	1,498	1,417
Prepaid income taxes	2,120	0
Prepaid expenses and other	5,055	2,824
Total current assets	69,938	57,877
Property and equipment, net	10,875	11,692
Financing receivables, net of current portion	19,263	11,485
Other assets, net of current portion	995	0
Intangible assets, net	86,226	96,713
Goodwill	140,449	140,449
Total assets	327,746	318,216
Current liabilities:
Accounts payable	5,668	7,620
Current portion of long-term debt	6,486	5,820
Deferred revenue	10,201	8,707
Accrued vacation	3,929	3,794
Income taxes payable	0	810
Other accrued liabilities	12,219	14,098
Total current liabilities	38,503	40,849
Long-term debt, net of current portion	124,583	136,614
Deferred tax liabilities	4,877	4,667
Total liabilities	167,963	182,130
Stockholders’ equity:
Common stock, $0.001 par value per share; 30,000 shares authorized; 14,083 and 13,760 shares issued and outstanding	14	14
Additional paid-in capital	164,793	155,078
Accumulated deficit	(5,024)	(19,006)
Total stockholders’ equity	159,783	136,086
Total liabilities and stockholders’ equity	$ 327,746	$ 318,216

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 2,124	$ 2,654
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	30,000,000	30,000,000
Common stock, shares issued (in shares)	14,083,000	13,760,000
Common stock, shares outstanding (in shares)	14,083,000	13,760,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Sales revenues:
Sales revenues:	$ 280,411	$ 276,927	$ 267,272
Costs of sales (exclusive of amortization shown separately below):
System sales and support	75,984	80,018	87,882
TruBridge	54,699	49,636	45,656
Total costs of sales	130,683	129,654	133,538
Gross profit	149,728	147,273	133,734
Operating expenses:
Product development	36,371	33,737	29,095
Sales and marketing	30,713	33,021	27,194
General and administrative	47,275	46,923	52,888
Amortization of acquisition-related intangibles	10,487	10,406	10,182
Goodwill impairment	0	28,000	0
Total operating expenses	124,846	152,087	119,359
Operating income (loss)	24,882	(4,814)	14,375
Other income (expense):
Other income	803	407	220
Loss on extinguishment of debt	0	(1,340)	0
Interest expense	(7,577)	(7,736)	(6,609)
Total other income (expense)	(6,774)	(8,669)	(6,389)
Income (loss) before taxes	18,108	(13,483)	7,986
Provision for income taxes	476	3,933	4,053
Net income (loss)	$ 17,632	$ (17,416)	$ 3,933
Net income (loss) per share - basic (in dollars per share)	$ 1.26	$ (1.27)	$ 0.29
Net income (loss) per share - diluted (in dollars per share)	$ 1.26	$ (1.27)	$ 0.29
Weighted average shares outstanding used in per common share computations:
Basic (in shares)	13,561	13,419	13,255
Diluted (in shares)	13,568	13,419	13,255
Product [Member]
Sales revenues:
Sales revenues:	$ 180,164	$ 188,261	$ 185,665
Service [Member]
Sales revenues:
Sales revenues:	$ 100,247	$ 88,666	$ 81,607

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 17,632	$ (17,416)	$ 3,933
Other comprehensive income (loss), net of tax
Change in unrealized income with realized income on the Statements of Operations	0	0	38
Total other comprehensive income (loss), net of tax	0	0	38
Comprehensive income (loss)	$ 17,632	$ (17,416)	$ 3,971

Consolidated Statements of Stoc

Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2015		11,303,000
Beginning balance at Dec. 31, 2015	$ 75,366	$ 11	$ 44,187	$ (38)	$ 31,206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	3,933				3,933
Change in unrealized income with realized income on the Statements of Operations	38			38
Issuance of restricted stock (in shares)		87,000
Issuance of restricted stock	0
Stock-based compensation	5,366		5,366
Dividends	(25,093)				(25,093)
Excess (deficit) tax benefit from share-based compensation	210		210
Common stock issued as consideration for acquisition of HHI (in shares)		1,974,000
Common stock issued as consideration for acquisition of HHI	89,803	$ 2	89,801
Fair value of options issued as consideration for acquisition of HHI	7,213		7,213
Common stock issued upon exercise of stock options (in shares)		169,000
Common stock issued upon exercise of stock options	1,134		1,134
Ending balance (in shares) at Dec. 31, 2016		13,533,000
Ending balance at Dec. 31, 2016	157,970	$ 13	147,911	0	10,046
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(17,416)				(17,416)
Change in unrealized income with realized income on the Statements of Operations	0
Issuance of restricted stock (in shares)		226,000
Issuance of restricted stock	1	$ 1
Stock-based compensation	7,166		7,166
Dividends	(11,636)				(11,636)
Common stock issued upon exercise of stock options (in shares)		1,000
Common stock issued upon exercise of stock options	1		1
Ending balance (in shares) at Dec. 31, 2017		13,760,000
Ending balance at Dec. 31, 2017	136,086	$ 14	155,078	0	(19,006)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	17,632				17,632
Change in unrealized income with realized income on the Statements of Operations	0
Issuance of restricted stock (in shares)		326,000
Issuance of restricted stock	0
Forfeiture of common stock (in shares)		(3,000)
Forfeiture of common stock	0
Stock-based compensation	9,715		9,715
Dividends	(5,620)				(5,620)
Ending balance (in shares) at Dec. 31, 2018		14,083,000
Ending balance at Dec. 31, 2018	$ 159,783	$ 14	$ 164,793	$ 0	$ (5,024)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating Activities
Net income (loss)	$ 17,632	$ (17,416)	$ 3,933
Adjustments to net income (loss):
Provision for bad debt	3,176	3,421	2,259
Deferred taxes	(364)	1,421	3,672
Stock based compensation	9,715	7,166	5,366
Excess tax benefit from shared-based compensation	0	0	(210)
Depreciation	1,795	2,473	3,062
Amortization of acquisition-related intangibles	10,487	10,406	10,182
Amortization of deferred finance costs	345	645	673
Goodwill impairment	0	28,000	0
Loss on extinguishment of debt	0	1,340	0
Changes in operating assets and liabilities (net of acquired assets and liabilities):
Accounts receivable	(3,898)	(7,847)	(3,927)
Financing receivables	(9,473)	(17,308)	1,514
Inventories	(81)	280	14
Prepaid expenses and other	549	(30)	1,787
Accounts payable	(1,952)	779	(5,588)
Deferred revenue	264	2,867	(13,662)
Other liabilities	(1,336)	6,069	(7,250)
Prepaid income taxes/income taxes payable	(2,930)	1,377	280
Net cash provided by operating activities	23,929	23,643	2,105
Investing Activities
Purchases of property and equipment	(978)	(726)	(39)
Purchase of business, net of cash received	0	0	(162,611)
Sale of investments	0	0	10,861
Net cash used in investing activities	(978)	(726)	(151,789)
Financing Activities
Dividends paid	(5,620)	(11,636)	(25,092)
Proceeds from long-term debt	0	0	121,397
Payments of long-term debt principal	(13,105)	(6,338)	(3,125)
Proceeds from revolving line of credit	7,300	777	35,000
Payments of revolving line of credit	(5,590)	(6,500)	(2,000)
Payments on capital lease	(315)	(296)	(71)
Payments of contingent consideration	(409)	(625)	(500)
Proceeds from exercise of stock options	0	1	1,134
Excess tax benefit from stock-based compensation	0	0	210
Net cash (used in) provided by financing activities	(17,739)	(24,617)	126,953
Increase (decrease) in cash and cash equivalents	5,212	(1,700)	(22,731)
Cash and cash equivalents at beginning of year	520	2,220	24,951
Cash and cash equivalents at end of year	5,732	520	2,220
Supplemental disclosure of cash flow information:
Cash paid for interest	7,138	6,953	5,876
Cash paid for income taxes, net of refund	3,771	1,134	110
Supplemental disclosure of non-cash flow information:
Fair value of common stock and options issued as consideration for acquisition of HHI	0	0	97,017
Write-off of fully depreciated assets	8,244	6,049	2,769
Capital lease obligation	$ 0	$ 0	$ 933

Nature of Operations

Nature of Operations	12 Months Ended
	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations	NATURE OF OPERATIONSComputer Programs and Systems, Inc. ("CPSI" or the "Company") is a healthcare information technology solutions provider which was formed and commenced operations in 1979. The Company provides, on an integrated basis, enterprise-wide clinical management, access management, patient financial management, health information management, strategic decision support, resource planning management and enterprise application integration solutions to healthcare organizations throughout the United States. Additionally, CPSI provides other information technology solutions, including business management services, remote hosting, networking technologies and other related services.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principles of Consolidation The consolidated financial statements of CPSI include the accounts of TruBridge, LLC ("TruBridge"), Evident, LLC ("Evident"), and Healthland Holding Inc. ("HHI"), all of which are wholly-owned subsidiaries of CPSI. The accounts of HHI include those of its wholly-owned subsidiaries, Healthland Inc. ("Healthland"), Rycan Technologies, Inc. ("Rycan"), and American HealthTech, Inc. ("AHT"). All significant intercompany balances and transactions have been eliminated. Presentation Effective January 1, 2018, our interface services team, which provides the design, development, implementation, and support services for all interfaces for data exchange from the CPSI applications and was previously considered a part of our product development division, has been integrated with our acute care client service team. This transition has worked to create a consistent, personal, and convenient service experience for our clients characterized by transparent communication with prompt resolution. With this change, the payroll and related costs of this group of employees that were formerly included within the caption "Product development" on our consolidated statements of operations are now included within the caption "System sales and support - Cost of sales." This reclassification had no effect on previously reported total sales revenues, operating income (loss), income (loss) before taxes or net income (loss). Amounts presented for the years ended December 31, 2017 and 2016, have been reclassified to conform to the current presentation. The following table provides the amounts reclassified for the year ended December 31, 2017: (In thousands) As previously reported Reclassifications As reclassified Costs of sales: System sales and support $ 75,994 4,024 $ 80,018 Operating expenses: Product development $ 37,761 (4,024) $ 33,737 The following table provides the amounts reclassified for the year ended December 31, 2016: (In thousands) As previously reported Reclassifications As reclassified Costs of sales: System sales and support $ 84,356 3,526 $ 87,882 Operating expenses: Product development $ 32,621 (3,526) $ 29,095 Cash and Cash Equivalents Cash and cash equivalents can include time deposits and certificates of deposit with original maturities of three months or less that are highly liquid and readily convertible to a known amount of cash. These assets are stated at cost, which approximates market value, due to their short duration or liquid nature. Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company establishes a general allowance for doubtful accounts based on collections history. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific allowance for doubtful accounts may be recorded to reduce the related receivable to the amount expected to be recovered. Financing Receivables Financing receivables are comprised of short-term payment plans and sales-type leases. Short-term payment plans are stated at the amount the Company expects to collect and do not bear interest. Sales-type leases are initially recorded at the present value of the related minimum lease payments, computed at the interest rate implicit in the lease, and are presented net of unearned income. Unearned income is amortized over the lease term to produce a constant periodic rate of return on the net investment in the lease (the interest method). An allowance for credit losses has been established for our financing receivables based on the historical level of customer defaults under such arrangements. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific reserve may be recorded to reduce the related receivable to the amount expected to be recovered. Customer payments are considered past due if a scheduled payment is not received within contractually agreed upon terms, with amounts reclassified to accounts receivable when they become due. As a result, we evaluate the credit quality of our financing receivables on an ongoing basis utilizing an aging of receivables and write-offs, customer collection experience, the customer’s financial condition and known risk characteristics impacting the respective customer base, as well as existing economic conditions, to determine if any further allowance is necessary. Amounts are specifically charged off once all available means of collection have been exhausted. Inventories Inventories are stated at lower of cost or net realizable value using the average cost method. The Company’s inventories are comprised of computer equipment, forms and supplies. For cash flow presentation, inventory used by the Company and capitalized as property and equipment is shown as a change in inventory. Property and Equipment Property and equipment is recorded at cost, less accumulated depreciation. Additions and improvements to property and equipment that materially increase productive capacity or extend the life of an asset are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. Upon retirement or other disposition of such assets, the related costs and accumulated depreciation are removed from the respective accounts and any resulting gain or loss is included in the results of operations. Depreciation expense is computed using the straight-line method over the asset’s useful life, which is generally 5 years for computer equipment, furniture, and fixtures and 30 years for buildings. Leasehold improvements are depreciated over the shorter of the asset’s useful life or the remaining lease term. The Company reviews for the possible impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation expense is reported in the consolidated statements of operations as a component of costs of sales and operating expenses. Business Combinations We apply business combination accounting when we acquire a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded in general and administrative expenses; restructuring costs associated with a business combination are expenses; contingent consideration is measured at fair value at the acquisition date, with changes in fair value after the acquisition date affecting earnings; changes in deferred tax asset valuation allowances and income tax uncertainties after the measurement period affect income tax expense; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets and liabilities acquired. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, are based on management's estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, or require acceleration of the amortization expense of finite-lived intangible assets. The results of the acquired businesses' operations are included in the Consolidated Statements of Operations of the combined entity beginning on the date of the acquisition. We have applied this acquisition method to the transactions described in Note 3 - Business Combination. Goodwill Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the identifiable net tangible and intangible assets acquired. Goodwill is not amortized but is evaluated for impairment annually or more frequently if indicators of impairment are present or changes in circumstances suggest that impairment may exist. We test annually for impairment as of October 1. As part of our annual goodwill impairment test, we first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we conduct a quantitative goodwill impairment assessment. The first step of the quantitative goodwill impairment test compares the fair value of the reporting unit with its carrying amount, including goodwill. The Company early adopted Accounting Standards Update 2017-04 on January 1, 2017, which eliminates the second step of the goodwill impairment analysis. Therefore, if the carrying amount of the reporting unit exceeds its fair value in the first step of the goodwill impairment test, an impairment charge is recognized for the amount by which the carrying amount exceeds the total amount of goodwill allocated to that reporting unit. If the fair value of the reporting unit exceeds its carrying amount, the goodwill of the reporting unit is not considered to be impaired. We did not identify any events or circumstances that would require interim goodwill impairment testing prior to October 1, 2017. Based on our assessment as of October 1, 2017, we determined that there was no impairment of goodwill for our Acute Care EHR and TruBridge reporting units. We also determined as of October 1, 2017, that it was more likely than not that we did not have an impairment of our Post-acute Care EHR reporting unit. During the fourth quarter of 2017, the cumulation of events, including anticipated attrition of significant post-acute customer accounts and a product development acceleration plan for our post-acute EHR software, triggered management to re-assess future discounted cash flow projections incorporated in the October 1, 2017 annual assessment to include updated assumptions for the aforementioned fourth quarter events impacting the Post-acute Care EHR reporting unit. The result of our fair value assessment, which applied a combination of the income and market valuation approach, measured the reporting unit's fair value less than the reporting unit's carrying value. A goodwill impairment of $28.0 million was recorded against our Post-acute Care EHR reporting unit for the year ended December 31, 2017. We determined there was no impairment to goodwill for the year ended December 31, 2018. Purchased Intangible Assets Purchased intangible assets are acquired in connection with a business acquisition, and are amortized over their estimated useful lives based on the pattern of economic benefit expected from each asset. We concluded for certain purchased intangible assets that the pattern of economic benefit approximated the straight-line method, and therefore, the use of the straight-line method was appropriate, as the majority of the cash flows will be recognized ratably over the estimated useful lives and there is no degradation of the cash flows over time. We assess the recoverability of intangible assets whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. The carrying amount is not recoverable if it exceeds the undiscounted sum of cash flows expected to result from the use and eventual disposition of the asset. If the asset is not recoverable, the impairment loss is measured by the excess of the asset's carrying amount over its fair value. During the fourth quarter of 2017, the cumulation of events, including anticipated attrition of significant post-acute customer accounts and a product development acceleration investment plan in our Post-acute Care EHR software, triggered management to assess the recoverability of purchased intangible assets related to our Post-acute Care EHR asset group. We determined there was no impairment to purchased intangible assets as of December 31, 2018 or 2017. Revenue Recognition Revenue is recognized upon transfer of control of promised products or services to clients in an amount that reflects the consideration we expect to receive in exchange for those products and services. We enter into contracts that can include various combinations of products and services, which are generally distinct and accounted for as separate performance obligations. The Company employs the 5-step revenue recognition model under ASC 606 to: (1) identify the contract with the client, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue is recognized net of shipping charges and any taxes collected from clients, which are subsequently remitted to governmental authorities. • System Sales and Support The Company enters into contractual obligations to sell perpetual software licenses, installation, conversion, and related training services, hardware and software application support, and hardware maintenance services to acute care and post-acute care community hospitals. • Non-recurring Revenues • Perpetual software licenses and installation, conversion, and related training services are not considered separate and distinct performance obligations due to the proprietary nature of our software and are, therefore, accounted for as a single performance obligation on a module-by-module basis. Revenue is recognized as each module's implementation is completed based on the module's stand-alone selling price ("SSP"), net of discounts. Fees for licenses and installation, conversion, and related training services are typically due in three installments: (1) at placement of order, (2) upon installation of software and commencement of training, and (3) upon satisfactory completion of monthly accounting cycle or end-of-month operation by application and as applicable for each application. Often, short-term and/or long-term financing arrangements are provided for software implementations; refer to Note 10 - Financing Receivables for further information. Electronic health records ("EHR") implementations include a system warranty that terminates thirty days from the software go-live date, the date which the client begins using the system in a live environment. • Hardware revenue is recognized separately from software licenses at the point in time it is delivered to the client. The SSP of hardware is cost plus a reasonable margin. Payment is generally due upon delivery of the hardware to the client. Standard manufacturer warranties apply to hardware. • Recurring Revenues • Software application support and hardware maintenance services sold with software licenses and hardware are separate and distinct performance obligations. Revenue for support and maintenance services is recognized based on SSP, which is the renewal price, ratably over the life of the contract, which is generally three to five years. Payment is due monthly for support services provided. • Subscriptions to third -party content revenue is recognized as a separate performance obligation ratably over the subscription term based on SSP, which is cost plus a reasonable margin. Payment is due monthly for subscriptions to third party content. • Software as a Service ("SaaS") arrangements for EHR software and related conversion and training services are considered a single performance obligation. Revenue is recognized on a monthly basis as the SaaS service is provided to the client over the contract term. Payment is due monthly for SaaS services provided. Refer to Note 17 for further information, including revenue by client base (acute care or post-acute care) bifurcated by recurring and non-recurring revenue. • TruBridge TruBridge provides an array of business processing services ("BPS") consisting of accounts receivable management, private pay services, insurance services, medical coding, electronic billing, statement processing, payroll processing, and contract management. Fees are recognized over the period of the client contractual relationship as the services are performed based on the SSP, net of discounts. Fees for many of these services are invoiced, and revenue recognized accordingly, based on the volume of transactions or a percentage of client accounts receivable collections. Payment is due monthly for BPS with certain amounts varying based on utilization and/or volumes. TruBridge also provides professional IT services. Revenue from professional IT services is recognized as the services are performed based on SSP. Payment is due monthly as services are performed. • Deferred Revenue Deferred revenue represents amounts invoiced to clients for which the services under contract have not been completed and revenue has not been recognized, including annual renewals of certain software subscriptions and customer deposits for implementations to be performed at a later date. Revenue is recognized ratably over the life of the software subscriptions as services are provided and at the point-in-time when implementations have been completed. (In thousands) For Year Ended December 31, 2018 Balance as of January 1, 2018 $ 9,937 Deferred revenue recorded 19,818 Less deferred revenue recognized as revenue (19,554) Balance as of December 31, 2018 $ 10,201 The deferred revenue recorded during the year December 31, 2018 is comprised primarily of the annual renewals of certain software subscriptions billed during the year and deposits collected for future EHR installations. The deferred revenue recognized as revenue during 2018 is comprised primarily of the periodic recognition of annual renewals that were deferred until earned and deposits for future EHR installations that were deferred until earned. • Costs to Obtain and Fulfill a Contract with a Customer Costs to obtain a contract include the commission costs related to SaaS arrangements, which are capitalized and amortized ratably over the expected life of the customer. As a practical expedient, we generally recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset would have been one year or less, with the exception of commissions generated from TruBridge sales. TruBridge commissions, which are paid up to twelve months in advance, are capitalized and amortized over the prepayment period. Costs to obtain a contract are expensed within sales and marketing expenses in the accompanying consolidated statements of operations. Contract fulfillment costs related to the implementation of SaaS arrangements are capitalized and amortized ratably over the expected life of the customer. Costs to fulfill contracts consist of the payroll costs for the implementation of SaaS arrangements, including time for training, conversion, and installation that is necessary for the software to be utilized. Contract fulfillment costs are expensed within the caption "System sales and support - Cost of sales" in the accompanying consolidated statements of operations. Costs to obtain and fulfill contracts related to SaaS arrangements are included within the "Prepaid expenses and other" and "Other assets, net of current portion" line items on our consolidated balance sheets. (In thousands) For Year Ended December 31, 2018 Balance as of January 1, 2018 $ 3,775 Costs to obtain and fulfill contracts capitalized 3,345 Less costs to obtain and fulfill contracts recognized as expense (4,103) Balance as of December 31, 2018 $ 3,017 • Significant Judgments Our contracts with clients often include promises to transfer multiple products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Judgment is required to determine SSP for each distinct performance obligation. We use observable SSP for items that are sold on a stand-alone basis to similarly situated clients at unit prices within a sufficiently narrow range. For performance obligations that are sold to different clients for a broad range of amounts, or for performance obligations that are never sold on a stand-alone basis, the residual method in determining SSP is applied and requires significant judgment. Allocating the transaction price, including estimating SSP of promised goods and services for contracts with discounts or variable consideration, may require significant judgment. Due to the short time frame of the implementation cycle, discount allocation is immaterial as revenue is recognized net of discounts within the same reporting period. In scenarios where the Company enters into a contract that includes both a software license and BPS or other services that are charged based on volume of services rendered, the Company allocates variable amounts entirely to a distinct good or service. The terms of the variable payment relate specifically to the entity’s efforts to satisfy that performance obligation. Significant judgment is required in determining the expected life of a customer, which is the amortization period for costs to obtain and fulfill a contract that have been capitalized. The Company determined that the expected life of the customer is not materially different from the initial contract term based on the characteristics of the SaaS offering. • Remaining Performance Obligations Disclosures regarding remaining performance obligations are not considered material as the overwhelming majority of the Company's remaining performance obligations either (a) are related to contracts with an expected duration of one year or less, or (b) exhibit revenue recognition in the amount to which the Company has the right to invoice. Stock-Based Compensation The Company accounts for stock-based compensation according to the provisions of FASB Codification topic, Compensation – Stock Compensation, which establishes accounting for stock-based awards exchanged for employee services. Accordingly, stock-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as an expense over the employee’s or non-employee director’s requisite service period. Product Development Costs Product development costs are expensed as incurred. Product development costs totaled approximately $36.4 million, $33.7 million, and $29.1 million for the years ended December 31, 2018, 2017 and 2016, respectively. Income Taxes We account for income taxes in accordance with FASB Codification topic, Income Taxes . Under this topic, deferred income taxes are determined utilizing the asset and liability approach. This method gives consideration to the future tax consequences associated with differences between financial accounting and tax bases of assets and liabilities. The effect on the deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We recognize interest and penalties accrued related to unrecognized tax benefits in the consolidated statements of operations as a component of the provision for income taxes. We also make a provision for uncertain income tax positions in accordance with the Income Taxes Codification topic. These provisions require that a tax position taken in a tax return be recognized in the financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon settlement. The topic also requires that changes in judgment that result in subsequent recognition, derecognition, or change in a measurement date of a tax position taken in a prior annual period (including any related interest and penalties) be recognized as a discrete item in the interim period in which the change occurs. Valuation allowances are recorded when, in the opinion of management, it is more likely than not that all or a portion of the deferred tax assets will not be realized. These valuation allowances can be impacted by changes in tax laws, changes to statutory tax rates, and future taxable income, and are based on our judgment, estimates, and assumptions. See Note 7 for the impact of H.R. 1, commonly known as the Tax Cuts and Jobs Act, which was signed into law on December 22, 2017. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported revenues and expenses during the reporting periods. Actual results could differ from those estimates. Segment Reporting Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, which we refer to as the CODM, or decision-making group in assessing performance and making decisions regarding resource allocation. The Company has prepared operating segment information based on the manner in which management disaggregates the Company's operations for making internal operating decisions. See Note 17. New Accounting Standards Adopted in 2018 In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU 2014-09, Revenue from Contracts with Customers , to clarify the principles for recognizing revenue and to develop a common revenue standard for U.S. GAAP and International Financial Reporting Standards. The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes prior revenue recognition guidance. This guidance was effective for fiscal years and interim periods within those years beginning after December 15, 2017, which was effective for the Company as of the first quarter of our fiscal year ended December 31, 2018. We adopted this new accounting standard codified as Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers , and the related amendments (the "new revenue standard") during the first quarter of 2018 and have applied it to all contracts using the modified retrospective method, pursuant to which the cumulative effect of initially applying the new revenue standard is recognized as an adjustment to retained earnings and impacted balance sheet line items as of January 1, 2018, the date of adoption. The comparative previous period information continues to be reported under the accounting standards in effect for that period. We completed an assessment of our systems, data, and processes that are affected by the implementation of this new revenue standard and have concluded that this standard does not significantly alter revenue recognition practices for our system sales and support and TruBridge revenue streams. The impact on our revenue recognition is limited to deferring and amortizing implementation fees over the contract life related to our Rycan revenue cycle management product, in which we previously recognized revenue as implementation was completed. Rycan implementation fees totaled $1.6 million in 2017, less than 1% of our 2017 revenues. The balance sheet impact of the deferred revenue related to these fees was an increase of $1.8 million as of the date of adoption. Also impacting deferred revenue was a decrease of $0.6 million related to previous billings which no longer required deferred recognition as of the date of adoption. In addition to revenue recognition, the new revenue standard impacts our consolidated financial statements with respect to the capitalization of certain commissions and contract fulfillment costs which were previously expensed as incurred. Commissions and contract fulfillment costs related to the implementation of software as a service arrangements are now capitalized and amortized over the expected life of the customer. TruBridge commissions, which are paid up to twelve months in advance, are now capitalized and amortized over the prepayment period. The balance sheet impact of the prepaid assets was an increase of $3.8 million as of the date of adoption. Due to the aforementioned changes in assets and liabilities related to the adoption of the new revenue standard, our deferred tax liability increased $0.6 million as of the date of adoption. In total, the adoption of ASU 2014-09 resulted in a net increase in retained earnings of $2.0 million as of the date of adoption. In accordance with the new revenue standard requirements, the disclosures of the impact of adoption on our consolidated statement of operations and balance sheet were as follows: For Year Ended December 31, 2018 (In thousands) As reported Balances without adoption of ASC 606 Effect of adoption increase/(decrease) Consolidated Statements of Operations Revenue: TruBridge $ 100,247 $ 100,264 $ (17) Cost of sales: System sales and support 75,984 75,857 127 Gross profit 149,728 149,872 (144) Sales and marketing 30,713 30,083 630 Operating income 24,882 25,656 (774) Provision for income taxes 476 638 (162) Net income $ 17,632 $ 18,244 $ (612) December 31, 2018 (In thousands) As reported Balances without adoption of ASC 606 Effect of adoption increase/(decrease) Consolidated Balance Sheet Prepaid assets and other $ 5,055 $ 3,032 $ 2,023 Other assets, net of current 995 — 995 Total assets 327,746 324,728 3,018 Deferred revenue 10,201 8,953 1,248 Deferred tax liability 4,877 4,466 411 Total liabilities 167,963 166,304 1,659 Accumulated deficit $ (5,024) $ (6,383) $ 1,359 The effects of the changes in balance sheet accounts resulting from the adoption of the new revenue standard are primarily due to the beginning adjustments for adoption mentioned above, accompanied by incremental changes resulting from activity during the period ended December 31, 2018. The new revenue standard requirements did not impact our net cash provided by or used in operating, investing, or financing cash flows on our consolidated statements of cash flows, although components within changes in operating assets and liabilities were immaterially impacted by adoption. In August 2016, the FASB issued ASU 2016-15, Classifications of Certain Cash Receipts and Cash Payments, which clarifies cash flow classification for eight specific issues, including debt prepayment or extinguishment costs, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, and proceeds from the settlement of corporate-owned life insurance policies. This guidance was effective for fiscal years and interim periods within those years beginning after December 15, 2017, which was effective for the Company as of the first quarter of our fiscal year ended December 31, 2018. The adoption of ASU 2016-15 did not have a material effect on our financial statements. In January 2017, the FASB issued ASU 2017-01, Clarifying the Definition of a Business, to assist an entity in evaluating when a set of transferred assets and activities is a business. The guidance was effective for fiscal years and interim periods within those years beginning after December 15, 2017, and will be applied prospectively to any transactions occurring following adoption. The adoption of ASU 2017-01 did not have a material effect on our financial statements. New Accounting Standards Yet to be Adopted In February 2016, the FASB issued ASU 2016-02, Leases , to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. The new guidance will require the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP. This guidance will be effective for fiscal years and interim periods within those years beginning after December 15, 2018, which will be effective for the Company as of the first quarter of our fiscal year end

Business Combination

Business Combination	12 Months Ended
	Dec. 31, 2018
Business Combinations [Abstract]
Business Combination	BUSINESS COMBINATION Acquisition of HHI On January 8, 2016, we acquired all of the assets and liabilities of HHI, including its wholly-owned subsidiaries, Healthland, AHT and Rycan. Healthland is a provider of electronic health records ("EHR") and clinical information management in the acute care market. AHT is a provider of clinical and financial solutions in the post-acute care market. Rycan offers SaaS-based revenue cycle management workflow and automation software to hospitals. We believe the acquisition of HHI: • strengthened our position in providing healthcare information systems to community healthcare organizations by combining hospital customers; • introduced CPSI to the post-acute care market; and • expanded the products offered by and capabilities of TruBridge with the addition of Rycan and its suite of revenue cycle management software products. These factors, combined with the synergies and economies of scale expected from combining the operations of CPSI and HHI, were the basis for the acquisition. Consideration for the acquisition included cash (net of cash of the acquired entities) of $162.6 million (inclusive of seller's transaction expenses), 1,973,880 shares of common stock of CPSI ("CPSI Common Stock"), and the assumption by CPSI of stock options that became exercisable for 174,972 shares of CPSI Common Stock. During 2015, we incurred approximately $3.0 million of pre-tax costs in connection with the acquisition of HHI. During the year ended December 31, 2016, we incurred approximately $8.2 million, of pre-tax acquisition costs in connection with the acquisition of HHI. We incurred no such costs during the year ended December 31, 2017 or 2018. Acquisition costs are included in general and administrative expenses in our consolidated statements of operations. (In thousands) Purchase Price Cash consideration, net of acquired cash received $ 162,611 Fair value of common stock and options issued as consideration 97,017 Total consideration $ 259,628 Our acquisition of HHI was treated as a purchase in accordance with Accounting Standards Codification (the "Codification") 805, Business Combinations , of the Financial Accounting Standards Board ("FASB"), which requires allocation of the purchase price to the estimated fair values of assets and liabilities acquired in the transaction. Our allocation of the purchase price was based on management's judgment after evaluating several factors, including a valuation assessment. The allocation of the purchase price paid for HHI was as follows: (In thousands) Purchase Price Allocation Acquired cash $ 5,371 Accounts receivable 5,789 Financing receivables 2,184 Inventories 216 Prepaid expenses 3,228 Property and equipment 1,263 Intangible assets 117,300 Goodwill 168,449 Accounts payable and accrued liabilities (17,490) Deferred taxes, net (4,010) Contingent consideration (1,620) Deferred revenue (15,681) Net assets acquired $ 264,999 The intangible assets in the table above are being amortized on a straight-line basis over their estimated useful lives. The amortization is included in amortization of acquisition-related intangibles in our consolidated statements of operations. Of the goodwill acquired, $23.3 million was expected to be tax deductible. The fair value measurements of tangible and intangible assets and liabilities were based on significant inputs not observable in the market and thus represent Level 3 measurements within the fair value measurement hierarchy (see Note 16). Level 3 inputs included, among others, discount rates that we estimated would be used by a market participant in valuing these assets and liabilities, projections of revenues and cash flows, client attrition rates and market comparables. The gross contractual amount of accounts receivable of HHI at the date of acquisition was $9.4 million. The following unaudited pro forma revenue, net income and earnings per share amounts for the year ended December 31, 2016 gives effect to the HHI acquisition as if it had been completed on January 1, 2015. The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of what the operating results actually would have been during the periods presented had the HHI acquisition been completed during the periods presented. In addition, the unaudited pro forma financial information does not purport to project future operating results. The pro forma information does not fully reflect: (1) any anticipated synergies (or costs to achieve synergies) or (2) the impact of non-recurring items directly related to the HHI acquisition. Year Ended December 31, (In thousands, except per share data, unaudited) 2016 Pro forma revenues $ 270,974 Pro forma net income $ 8,538 Pro forma diluted earnings per share $ .64 Pro forma net income was calculated by adjusting the results for the applicable period to reflect (i) the additional amortization that would have been charged assuming the fair value adjustments to intangible assets had been applied on January 1, 2015 and (ii) adjustments to amortized revenue during fiscal 2016 as a result of the acquisition date valuation of assumed deferred revenue. The pro forma results for each period also reflect the pro forma adjustment to interest expense as a result of the incurrence of new debt to finance the acquisition and elimination of Healthland debt in conjunction with the acquisition. The Company incurred $5.5 million in 2016 acquisition-related costs, which are included in general and administrative expense in the Company’s statement of income for the year ended December 31, 2016, that is reflected in pro forma net income for the year ended December 31, 2015. Severance and integration costs of $2.7 million were not included in the acquisition costs for the purpose of calculating the pro forma results.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
Property and Equipment	PROPERTY AND EQUIPMENT Property and equipment were comprised of the following at December 31, 2018 and 2017: (In thousands) 2018 2017 Land $ 2,848 $ 2,848 Buildings and improvements 7,752 8,240 Computer equipment 2,766 3,245 Leasehold improvements 1,198 5,001 Office furniture and fixtures 1,938 2,462 Automobiles 18 70 16,520 21,866 Less: accumulated depreciation (5,645) (10,174) Property and equipment, net $ 10,875 $ 11,692

Other Accrued Liabilities

Other Accrued Liabilities	12 Months Ended
	Dec. 31, 2018
Payables and Accruals [Abstract]
Other Accrued Liabilities	OTHER ACCRUED LIABILITIES Other accrued liabilities were comprised of the following at December 31, 2018 and 2017: (In thousands) 2018 2017 Salaries and benefits $ 8,722 $ 8,432 Severance 992 1,139 Commissions 830 2,416 Self-insurance reserves 1,017 1,024 Contingent consideration 206 586 Other 452 501 Other accrued liabilities $ 12,219 $ 14,098

Net Income Per Share

Net Income Per Share	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Net Income Per Share	NET INCOME PER SHARE The Company presents basic and diluted earnings per share ("EPS") data for its common stock. Basic EPS is calculated by dividing the net income attributable to stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is determined by adjusting the net income attributable to stockholders of the Company and the weighted average number of shares of common stock outstanding during the period for the effects of all dilutive potential common shares, including awards under stock-based compensation arrangements. The Company's unvested restricted stock awards (see Note 8) are considered participating securities under FASB Codification topic, Earnings Per Share , because they entitle holders to non-forfeitable rights to dividends until the awards vest or are forfeited. When a company has a security that qualifies as a "participating security," the Codification requires the use of the two-class method when computing basic EPS. The two-class method is an earnings allocation formula that determines EPS for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net income to allocate to common stockholders, income is allocated to both common stock and participating securities based on their respective weighted average shares outstanding for the period, with net income attributable to common stockholders ultimately equaling net income less net income attributable to participating securities. Diluted EPS for the Company's common stock is computed using the more dilutive of the two-class method or the treasury stock method. The following is a calculation of the basic and diluted EPS for the Company's common stock, including a reconciliation between net income (loss) and net income (loss) attributable to common stockholders for the years ended December 31, 2018, 2017, and 2016: (In thousands, except for per share data) 2018 2017 2016 Basic EPS Numerator Net income (loss) $ 17,632 $ (17,416) $ 3,933 Less: Net (income) loss attributable to participating securities (595) 316 (38) Net income (loss) attributable to common stockholders $ 17,037 $ (17,100) $ 3,895 Denominator Weighted average shares outstanding used in basic per common share computations 13,561 13,419 13,255 Basic EPS $ 1.26 $ (1.27) $ .29 Diluted EPS Numerator Net income (loss) attributable to common stockholders $ 17,037 $ (17,100) $ 3,895 Reallocation of net income (loss) attributable to participating securities — — — Net income (loss) attributable to common stockholders for diluted EPS $ 17,037 $ (17,100) $ 3,895 Denominator Weighted average shares outstanding used in basic per common share computations 13,561 13,419 13,255 Weighted average effect of dilutive securities: Performance share awards 7 — — Weighted average shares outstanding used in diluted per common share computations 13,568 13,419 13,255 Diluted EPS $ 1.26 $ (1.27) $ .29

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES The Company accounts for income taxes in accordance with the FASB’s Codification topic, Income Taxes . These provisions require a company to determine whether it is more likely than not that a tax position will be sustained upon examination based on the technical merits of the position. If the more-likely-than-not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements. The Company did not have any unrecognized tax positions as of December 31, 2018 and 2017. The federal returns for tax years 2015 through 2017 remain open to examination, and the tax years 2014 through 2017 remain open to examination by certain other taxing jurisdictions to which the Company is subject. Additional years may be open to the extent attributes are being carried forward to an open year. Deferred income taxes arise from the temporary differences in the recognition of income and expenses for tax purposes. A valuation allowance is established when the Company believes that it is more likely than not that some portion of its deferred tax assets will not be realized. On December 22, 2017, H.R. 1, commonly known as the Tax Cuts and Jobs Act (the "Act"), was signed into law. Among other things, the Act reduced our corporate federal tax rate from 35% to 21% effective January 1, 2018. As a result we are required to re-measure, through income tax expense, our deferred tax assets and liabilities using the enacted rate at which we expect them to be recovered or settled. The re-measurement of our net deferred tax liability resulted in an additional tax benefit of $1.9 million for the period ended December 31, 2017. Deferred tax assets and liabilities were comprised of the following at December 31, 2018 and 2017: (In thousands) 2018 2017 Deferred tax assets: Accounts receivable and financing receivables $ 1,112 $ 1,395 Accrued vacation 529 519 Stock-based compensation 2,264 1,416 Deferred revenue 250 132 Accrued severance 173 207 Accrued liabilities and other — 884 Fixed assets — 172 Credits 1,984 — Net operating loss 10,347 13,261 Deferred tax assets 16,659 17,986 Less: Valuation allowance 456 1,605 Total deferred tax assets $ 16,203 $ 16,381 Deferred tax liabilities: Intangible assets $ 19,957 $ 21,048 Accrued liabilities and other 897 — Fixed assets 226 — Total deferred tax liabilities $ 21,080 $ 21,048 Total net deferred tax liability $ (4,877) $ (4,667) Significant components of the income tax provision for the years ended December 31, 2018, 2017 and 2016 were as follows: (In thousands) 2018 2017 2016 Current provision: Federal $ (594) $ 1,535 $ (72) State 1,434 977 453 Deferred provision: Federal 649 1,070 4,144 State (1,013) 351 (472) Total income tax provision $ 476 $ 3,933 $ 4,053 The difference between income taxes at the U.S. federal statutory income tax rate of 21% for year ended December 31, 2018, and 35% for years ended December 31, 2017 and 2016, and those reported in the consolidated statements of operations for the years ended December 31, 2018, 2017 and 2016 are as follows: (In thousands) 2018 2017 2016 Income taxes at U.S. federal statutory rate $ 3,803 $ (4,584) $ 2,795 Provision-to-return adjustments (112) 433 325 State income tax, net of federal tax effect 1,109 458 5 Domestic production activities deduction — (280) — Tax credits (3,428) (393) (349) Transaction costs — — 1,312 Goodwill impairment — 9,520 — Stock-based compensation 356 1,155 — Deferred impact of tax reform — (1,890) — Change in valuation allowance (1,149) (304) — Other (103) (182) (35) Total income tax provision $ 476 $ 3,933 $ 4,053 Our effective tax rates for the years ended December 31, 2018, 2017 and 2016 were 3%, (29)% and 51%, respectively. Our effective tax rate for 2018 was impacted by the reduction in our corporate federal tax rate from 35% to 21% effective at the beginning of 2018. In addition, our implementation of ASC 730 Safe Harbor Directive has significantly increased our estimated R&D tax credits for the 2017 and 2018 tax years, resulting in a further decrease in our effective rate for 2018. Our effective tax rate for the year ended December 31, 2017 was significantly impacted by tax shortfalls related to stock-based compensation resulting from our adoption of ASU 2016-09, the non-deductible nature of our goodwill impairment charges, and the effect of recent tax reform legislation. These three factors combined for a net $8.8 million tax expense impact during 2017, affecting the period's effective tax rate by approximately 65%. Our effective tax rate for the year ended December 31, 2016 was uncharacteristically high, primarily due to permanent non-deductible acquisition transaction costs of $3.8 million. We have federal net operating loss carryfowards related to the acquisition of HHI of $70.5 million, $53.9 million, and $40.5 million for years ending December 31, 2016, 2017, and 2018, respectively, which expire at various dates from 2028 to 2035. We have state net operating loss carryforwards related to the acquisition of HHI of $46.5 million, $37.1 million, a nd $34.5 million for years ending December 31, 2016, 2017, and 2018, respectively, which expire at various dates from 2019 to 2035. Realization of deferred tax assets associated with the state net operating loss carryforward is dependent upon generating sufficient taxable income prior to their expiration. We believe it is more likely than not that the benefit from certain state NOL carryforwards will not be realized. In recognition of this risk, we have provided a valuation allowance on the deferred tax assets related to these state NOL carryforwards of $1.6 million after December 31, 2017 and $0.5 million after December 31, 2018. The change in valuation allowance was based on evidence supporting that valuation allowances are not needed and should be released for HHI's standalone NOLs.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation	STOCK-BASED COMPENSATION The Company's stock-based compensation awards are in the form of restricted stock and performance share awards granted pursuant to the Company's 2012 Restricted Stock Plan for Non-Employee Directors and Amended and Restated 2014 Incentive Plan (the "Plans"). Stock-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as an expense over the employee’s or non-employee director’s requisite service period. As of December 31, 2018, there were a total of 324,257 shar es of common stock reserved under the Plans for issuance under future share-based payment arrangements. The following table details total stock-based compensation expense for the years ended December 31, 2018, 2017 and 2016, included in the consolidated statements of operations: (In thousands) 2018 2017 2016 Costs of sales $ 2,134 $ 1,750 $ 1,396 Operating expenses 7,581 5,416 3,970 Pre-tax stock-based compensation expense 9,715 7,166 5,366 Less: income tax effect (2,040) (2,795) (2,093) Net (after tax) stock-based compensation expense $ 7,675 $ 4,371 $ 3,273 As of December 31, 2018, there was $12.9 million of unrecognized compensation cost related to non-vested stock-based compensation arrangements granted under the Plans, which is expected to be recognized over a weighted-average period of 1.9 years. Restricted Stock The Company grants restricted stock to executive officers, certain key employees and non-employee directors under the Plans with the fair value of the awards representing the fair value of the common stock on the date the restricted stock is granted. Shares of restricted stock generally vest in equal annual installments over the applicable vesting period, which ranges from one to three years. The Company records expenses for these grants on a straight-line basis over the applicable vesting periods. Shares of restricted stock may also be issued pursuant to the settlement of performance share awards, for which the Company records expenses in the manner described in the "Performance Share Awards" section below. A summary of restricted stock activity (including shares of restricted stock issued pursuant to the settlement of performance share awards) under the Plans during the years ended December 31, 2018, 2017 and 2016 is as follows: Shares Weighted-Average Grant-Date Fair Value Nonvested stock outstanding at January 1, 2016 191,397 $ 57.12 Granted 86,984 52.21 Vested (93,496) 57.48 Nonvested stock outstanding at December 31, 2016 184,885 $ 54.63 Granted 225,954 32.79 Vested (101,644) 55.58 Nonvested stock outstanding at December 31, 2017 309,195 $ 38.36 Granted 148,841 30.20 Performance share awards converted to restricted stock 177,395 29.94 Vested (156,988) 40.52 Forfeited (3,311) 30.20 Nonvested stock outstanding at December 31, 2018 475,132 $ 32.00 Performance Share Awards The Company grants performance share awards to executive officers and certain key employees under the Amended and Restated 2014 Incentive Plan. The number of shares of common stock earned and issuable under each award is determined at the end of each one three three One Three In the event that the Company's financial performance meets the predetermined targets for the performance objectives of the one three The recipients of performance share awards do not receive dividends or possess voting rights during the performance period and, accordingly, the fair value of the one-year performance share awards is the quoted market value of CPSI's common stock on the grant date less the present value of the expected dividends not received during the relevant period. The TSR modifier applicable to the three-year performance share awards is considered a market condition and therefore is reflected in the grant date fair value of the award. A Monte Carlo simulation has been used to account for this market condition in the grant date fair value of the award. Expense of one-year performance share awards is recognized using the accelerated attribution (graded vesting) method over the period beginning on the date the Company determines that it is probable that the performance criteria will be achieved and ending on the last day of the vesting period for the restricted stock issued in satisfaction of such awards. Expense of three-year performance share awards is recognized using ratable straight-line amortization over the three-year performance period. In the event the Company determines it is no longer probable that the minimum performance level will be achieved, all previously recognized compensation expense related to the applicable awards is reversed in the period such a determination is made. A summary of performance share award activity under the 2014 Incentive Plan for the years ended December 31, 2018, 2017 and 2016, is as follows, based on the target award amounts set forth in the performance share award agreements: Shares Weighted-Average Grant-Date Fair Value Performance share awards outstanding at January 1, 2016 49,471 $ 49.29 Granted 77,594 49.64 Forfeited or unearned (49,471) 49.29 Performance share awards outstanding at December 31, 2016 77,594 $ 49.64 Granted 189,325 29.94 Forfeited or unearned (77,594) 49.64 Performance share awards outstanding at December 31, 2017 189,325 $ 29.94 Granted 184,776 30.15 Forfeited or unearned (11,930) 29.94 Performance share awards converted to restricted stock (177,395) 29.94 Performance share awards outstanding at December 31, 2018 184,776 $ 30.15

Concentration of Credit Risk

Concentration of Credit Risk	12 Months Ended
	Dec. 31, 2018
Risks and Uncertainties [Abstract]
Concentration of Credit Risk	CONCENTRATION OF CREDIT RISK Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of temporary cash investments and trade receivables (including financing receivables). The Company places its temporary cash investments with credit-worthy, high-quality financial institutions. The Company’s customer base is concentrated in the healthcare industry. Customers are located throughout the United States. The Company requires no collateral or other security to support customer trade receivables. An allowance for doubtful accounts and allowance for credit losses has been established for potential credit losses based on historical collection experience.

Financing Receivables

Financing Receivables	12 Months Ended
	Dec. 31, 2018
Receivables [Abstract]
Financing Receivables	FINANCING RECEIVABLES Total financing receivables were $34.3 million as of December 31, 2018, compared with $26.5 million as of December 31, 2017. Short-Term Payment Plans The Company provides fixed monthly payment arrangements ("short-term payment plans") over terms ranging from three to twelve months for meaningful use stage three and other add-on software installations. As a practical expedient, we do not adjust the amount of consideration recognized as revenue for the financing component as unearned income when we expect payment within one year or less. These receivables, included in the current portion of financing receivables, were comprised of the following on December 31, 2018 and 2017: (In thousands) 2018 2017 Short-term payment plans, gross $ 5,773 $ 9,081 Less: allowance for losses (404) (638) Short-term payment plans, net $ 5,369 $ 8,443 Long-Term Financing Arrangements Additionally, the Company provides financing for purchases of its information and patient care systems to certain healthcare providers under long-term financing arrangements expiring in various years through 2025. Under long-term financing arrangements, the transaction price is adjusted by a discount rate that reflects market conditions and that would be used for a separate financing transaction between the Company and licensee at contract inception, and takes into account the credit characteristics of the licensee and market interest rates as of the date of the agreement. As such, the amount of fixed fee revenue recognized at the beginning of the license term will be reduced by the calculated financing component. As payments are received from the licensee, the Company recognizes a portion of the financing component as interest income, reported as other income in the consolidated statements of operations. These receivables typically have terms from two to seven years. The components of these receivables were as follows on December 31: (In thousands) 2018 2017 Long-term financing arrangements, gross $ 34,841 $ 22,968 Less: allowance for losses (2,163) (2,606) Less: unearned income (3,725) (2,265) Long-term financing arrangements, net $ 28,953 $ 18,097 Future minimum payments to be received subsequent to December 31, 2018 are as follows: (In thousands) 2019 $ 10,825 2020 9,098 2021 6,942 2022 4,792 2023 2,423 Thereafter 761 Total minimum payments to be received 34,841 Less: allowance for losses (2,163) Less: unearned income (3,725) Receivables, net $ 28,953 Credit Quality of Financing Receivables and Allowance for Credit Losses The following table is a roll-forward of the allowance for financing credit losses for the years ended December 31, 2018 and 2017: (In thousands) Beginning Balance Provision Charge-offs Recoveries Ending Balance December 31, 2018 $ 3,244 $ 1,691 $ (2,368) $ — $ 2,567 December 31, 2017 $ 2,198 $ 1,823 $ (777) $ — $ 3,244 The Company’s financing receivables are comprised of a single portfolio segment, as the balances are all derived from short-term payment plan arrangements and long-term financing arrangements within our target market of community hospitals. The Company evaluates the credit quality of its financing receivables based on a combination of factors, including, but not limited to, customer collection experience, economic conditions, the customer’s financial condition, and known risk characteristics impacting the respective customer base of community hospitals, the most notable of which relate to enacted and potential changes in Medicare and Medicaid reimbursement rates as community hospitals typically generate a significant portion of their revenues and related cash flows from beneficiaries of these programs. In addition to specific account identification, the Company utilizes historical collection experience to establish the allowance for credit losses. Financing receivables are written off only after the Company has exhausted all collection efforts. Customer payments are considered past due if a scheduled payment is not received within contractually agreed upon terms. To facilitate customer collection and credit monitoring efforts, financing receivable amounts are invoiced and reclassified to trade accounts receivable when they become due, with all invoiced amounts placed on nonaccrual status. As a result, all past due amounts related to the Company’s financing receivables are included in trade accounts receivable in the accompanying consolidated balance sheets. The following is an analysis of the age of financing receivables amounts (excluding short-term payment plans) that have been reclassified to trade accounts receivable and were past due as of December 31, 2018 and December 31, 2017: (In thousands) 1 to 90 Days Past Due 91 to 180 Days Past Due 181 + Days Past Due Total Past Due December 31, 2018 $ 1,302 $ 210 $ 245 $ 1,757 December 31, 2017 $ 980 $ 171 $ — $ 1,151 For the year ended December 31, 2018, amounts considered past due i ncreased by $0.6 million compa red with the year ended December 31, 2017. From time to time, the Company may agree to alternative payment terms outside of the terms of the original financing receivable agreement due to customer difficulties in achieving the original terms. In general, such alternative payment arrangements do not result in a re-aging of the related receivables. Rather, payments pursuant to any alternative payment arrangements are applied to the already outstanding invoices beginning with the oldest outstanding invoices as the payments are received. Because amounts are reclassified to trade accounts receivable when they become due, there are no past due amounts included within the financing receivables or the financing receivables, current portion, net amounts in the accompanying consolidated balance sheets. The Company utilizes an aging of trade accounts receivable as the primary credit quality indicator for its financing receivables, which is facilitated by the reclassification of customer payment amounts to trade accounts receivable when they become due. The table below categorizes customer financing receivable balances (excluding short term payment plans), none of which are considered past due, based on the age of the oldest payment outstanding that has been reclassified to trade accounts receivable: (In thousands) December 31, 2018 December 31, 2017 Stratification of uninvoiced client financing receivables based on aging of related trade accounts receivable: 1 to 90 Days Past Due $ 17,290 $ 11,300 91 to 180 Days Past Due 2,247 3,727 181+ Days Past Due 885 967 Total uninvoiced client financing receivables balances of clients with a trade accounts receivable $ 20,422 $ 15,994 Total uninvoiced client financing receivables of clients with no related trade accounts receivable 10,694 4,709 Total financing receivables with contractual maturities of one year or less 5,773 9,081 Less: allowance for losses (2,567) (3,244) Total financing receivables $ 34,322 $ 26,540

Intangible Assets and Goodwill

Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	INTANGIBLE ASSETS AND GOODWILL Our purchased definite-lived intangible assets as of December 31, 2018 and 2017 are summarized as follows: (In thousands) Customer Relationships Trademark Developed Technology Total Gross carrying amount $ 82,300 $ 10,900 $ 24,100 $ 117,300 Accumulated amortization as of December 31, 2017 (12,937) (1,682) (5,968) (20,587) Net intangible assets as of December 31, 2017 69,363 9,218 18,132 96,713 Amortization expenses for year ended December 31, 2018 (6,539) (931) (3,017) (10,487) Net intangible assets as of December 31, 2018 $ 62,824 $ 8,287 $ 15,115 $ 86,226 Weighted average remaining years of useful life 10 12 5 9 The following table represents the remaining amortization of definite-lived intangible assets as of December 31, 2018: (In thousands) For the year ended December 31, 2019 $ 10,072 2020 10,066 2021 10,066 2022 10,066 2023 10,066 Due thereafter 35,890 Total $ 86,226 The following table sets forth the change in the carrying amount of goodwill by segment for the years ended December 31, 2018, 2017, and 2016: (In thousands) Acute Care EHR Post-acute Care EHR TruBridge Total Balance as of December 31, 2015 $ — $ — $ — $ — Goodwill acquired 97,095 57,570 13,784 168,449 Balance as of December 31, 2016 97,095 57,570 13,784 168,449 Goodwill impairment — (28,000) — (28,000) Balance as of December 31, 2017 and 2018 $ 97,095 $ 29,570 $ 13,784 $ 140,449 During 2017, the result of our fair value assessment of the Post-acute Care EHR reporting unit, which applied a combination of the income and market valuation approach, measured the reporting unit's fair value less than the reporting unit's carrying value. A goodwill impairment of $28.0 million was recorded against our Post-acute Care EHR reporting unit as of December 31, 2017 as a result of anticipated attrition of significant post-acute customer accounts and a product development acceleration plan for our post-acute EHR software. We determined there was no impairment to goodwill as of December 31, 2018 or December 31, 2016.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Long-Term Debt	LONG-TERM DEBT Long-term debt was comprised of the following at December 31, 2018 and 2017: (In thousands) December 31, 2018 December 31, 2017 Term loan facility $ 102,432 115,538 Revolving credit facility 29,693 27,983 Capital lease obligation 250 565 Debt obligations 132,375 144,086 Less: debt issuance costs (1,306) (1,652) Debt obligation, net 131,069 142,434 Less: current portion (6,486) (5,820) Long-term debt $ 124,583 $ 136,614 As of December 31, 2018, the carrying value of debt approximates the fair value due to the variable interest rate which reflects market rates. Credit Agreement In conjunction with our acquisition of HHI in January 2016, we entered into a syndicated credit agreement with Regions Bank ("Regions") serving as administrative agent, which provided for a $125 million term loan facility and a $50 million revolving credit facility. On October 13, 2017, we entered into a Second Amendment to refinance and decrease the aggregate principal amount of the credit facilities from $175 million to $162 million, which included a $117 million term loan facility and a $45 million revolving credit facility. On February 8, 2018, we entered into a Third Amendment to the credit agreement to increase the aggregate principal amount of our credit facilities from $162 million to $167 million, which includes a $117 million term loan facility and a $50 million revolving credit facility. Each of our credit facilities continues to bear interest at a rate per annum equal to an applicable margin plus, at our option, either (1) the Adjusted LIBOR rate for the relevant interest period, (2) an alternate base rate determined by reference to the greater of (a) the prime lending rate of Regions, (b) the federal funds rate for the relevant interest period plus one half of one percent per annum and (c) the one month LIBOR rate plus one percent per annum, or (3) a combination of (1) and (2). The applicable margin range for LIBOR loans and the letter of credit fee ranges from 2.0% to 3.5%. The applicable margin range for base rate loans ranges from 1.0% to 2.5%, in each case based on the Company's consolidated leverage ratio. Principal payments with respect to the term loan facility are due on the last day of each fiscal quarter beginning December 31, 2017, with quarterly principal payments of approximately $1.46 million through September 30, 2019, approximately $2.19 million through September 30, 2021 and approximately $2.93 million through September 30, 2022, with maturity on October 13, 2022 or such earlier date as the obligations under the credit agreement become due and payable pursuant to the terms of the credit agreement. Any principal outstanding under the revolving credit facility is due and payable on the maturity date. Anticipated annual future maturities of the term loan facility, revolving credit facility, and capital lease obligation are as follows as of December 31, 2018: (In thousands) 2019 $ 6,831 2020 8,775 2021 9,506 2022 107,263 Thereafter — $ 132,375 Our credit facilities are secured pursuant to a Pledge and Security Agreement, dated January 8, 2016, among the parties identified as obligors therein and Regions, as collateral agent, on a first priority basis by a security interest in substantially all of the tangible and intangible assets (subject to certain exceptions) of the Company and certain subsidiaries of the Company, as guarantors (collectively, the “Subsidiary Guarantors”), including certain registered intellectual property and the capital stock of certain of the Company’s direct and indirect subsidiaries. Our obligations under the credit agreement are also guaranteed by the Subsidiary Guarantors. The credit agreement, as amended by the Third Amendment, provides incremental facility capacity of $50 million, subject to certain conditions. The credit agreement includes a number of restrictive covenants that, among other things and in each case subject to certain exceptions and baskets, impose operating and financial restrictions on the Company and the Subsidiary Guarantors, including the ability to incur additional debt; incur liens and encumbrances; make certain restricted payments, including paying dividends on the Company's equity securities or payments to redeem, repurchase or retire the Company's equity securities (which are subject to our compliance, on a pro forma basis to give effect to the restricted payment, with the fixed charge coverage ratio and consolidated leverage ratio described below); enter into certain restrictive agreements; make investments, loans and acquisitions; merge or consolidate with any other person; dispose of assets; enter into sale and leaseback transactions; engage in transactions with affiliates; and materially alter the business we conduct. The credit agreement requires the Company to maintain a minimum fixed charge coverage ratio of 1.25:1.00 throughout the duration of such agreement. Under the credit agreement, the Company is required to comply with a maximum consolidated leverage ratio of 3.95:1.00 through December 31, 2017 and 3.50:1.00 from January 1, 2018 and thereafter. The credit agreement also contains customary representations and warranties, affirmative covenants and events of default. We believe that we were in compliance with the covenants contained in the credit agreement as of December 31, 2018. The dividend restriction in the credit agreement provides that no dividends may be paid unless there is no existing default, the dividend will not cause the Company to be out of compliance with the Company’s debt covenants, and as of any date of determination, the aggregate amount of dividends and other distributions made by the Company in any specified period (including the dividend or distribution to be paid on such date) shall not exceed the lesser of (A) the aggregate amount of the Company’s publicly announced dividend policy in effect for each fiscal quarter for the period of four full fiscal quarters most recently ended prior to such date or (B) 70% of the non-GAAP earnings per share for the period of four full fiscal quarters most recently ended prior to such date, calculated by the Company in good faith, in a manner consistent with past practices. For purposes of this restriction, “specified period” means, the period (x) commencing on the first day of the three full fiscal quarter period most recently ended prior to such date through (y) such date of determination. As of December 31, 2018, the Company had the capacity under the credit agreement to pay up to $18.3 million in additional dividends. The credit agreement requires the Company to mandatorily prepay our credit facilities with (i) 75% of excess cash flow (minus certain specified other payments) during each of the fiscal years ending December 31, 2017 and December 31, 2018 and (ii) 50% of excess cash flow (minus certain specified other payments) during the fiscal year ending December 31, 2019 and thereafter. The Company is permitted to voluntarily prepay our credit facilities at any time without penalty, subject to customary “breakage” costs with respect to prepayments of LIBOR rate loans made on a day other than the last day of any applicable interest period. The excess cash flow mandatory prepayment requirement under the credit agreement resulted in a $7.3 million prepayment on the term loan facility during the first quarter of 2018 related to excess cash flow generated by the Company during 2017. This mandatory prepayment was funded by drawing down on the revolving credit facility, as excess cash flow generated by the Company during 2017 was primarily used to voluntarily prepay amounts due under the revolving credit facility.

Benefit Plans

Benefit Plans	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Benefit Plans	BENEFIT PLANS In January 1994, the Company adopted the CPSI 401(k) Retirement Plan that covers all eligible employees of the Company who have completed one year of service. The plan allows eligible employees to contribute up to 60% of their pre-tax earnings up to the statutory limit prescribed by the Internal Revenue Service. The Company matches a discretionary amount determined by the Board of Directors. The Company contributed approximately $2.6 million, $2.6 million, and $2.8 million to the plan for the years ended December 31, 2018, 2017 and 2016, respectively. The Company provides certain health and medical benefits to eligible employees, their spouses and dependents pursuant to a benefit plan funded by the Company. Each participating employee contributes to the Company’s costs associated with such benefit plan. The Company’s obligation to fund this benefit plan and pay for these benefits is limited through the Company’s purchase of an insurance policy from a third-party insurer. The amount established as a reserve is intended to recognize the Company’s estimated obligations with respect to its payment of claims and claims incurred but not yet reported under the benefit plan. Management believes that the recorded liability for medical self-insurance at December 31, 2018 and 2017 is adequate to cover the losses and claims incurred, but these reserves are based on estimates and the amount ultimately paid may be more or less than such estimates.

Operating Leases

Operating Leases	12 Months Ended
	Dec. 31, 2018
Leases [Abstract]
Operating Leases	OPERATING LEASES The Company leased office space during 2018 in various locations in Alabama, Louisiana, Pennsylvania, Minnesota, Colorado, and Mississippi. These leases have terms expiring from 2019 through 2030 but do contain optional extension terms. The future minimum lease payments payable under these operating leases subsequent to December 31, 2018 are as follows: (In thousands) 2019 $ 1,482 2020 997 2021 960 2022 887 2023 844 Thereafter 2,515 $ 7,685 Total rent expense for the years ended December 31, 2018, 2017, and 2016 was $2.6 million, $2.6 million, $2.7 million, respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIESFrom time to time, the Company is involved in routine litigation that arises in the ordinary course of business. Management does not believe it is reasonably possible that such matters will have a material adverse effect on the Company’s financial statements.

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Fair Value	FAIR VALUE FASB Codification topic, Fair Value Measurements and Disclosures, establishes a framework for measuring fair value and expands financial statement disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Codification topic does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. The Codification topic requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data. The accrued contingent consideration depicted below represents the remaining potential earnout incentive for former Rycan shareholders, relating to the purchase of Rycan by HHI in 2015. As a result of 2018 Rycan performance, former Rycan shareholders earned the entirety of the remaining potential earnout. A payout of $409,000 was paid prior to December 31, 2018, and the remaining balance as of December 31, 2018 was paid subsequently. We have estimated the fair value of the remaining contingent consideration based on the amount of revenue that was earned by Rycan for the year ended December 31, 2018 in accordance with the agreement. Fair Value at December 31, 2018 Using Quoted Prices in Carrying Active Markets for Significant Other Significant Amount at Identical Assets Observable Inputs Unobservable Inputs (In thousands) 12/31/2018 (Level 1) (Level 2) (Level 3) Description Contingent consideration $ 206 $ — $ — $ 206 Total $ 206 $ — $ — $ 206 The following table summarizes the carrying amounts and fair values of certain assets at December 31, 2017: Fair Value at December 31, 2017 Using Quoted Prices in Carrying Active Markets for Significant Other Significant Amount at Identical Assets Observable Inputs Unobservable Inputs (In thousands) 12/31/2017 (Level 1) (Level 2) (Level 3) Description Contingent consideration $ 586 $ — $ — $ 586 Total $ 586 $ — $ — $ 586 The carrying amount of other financial instruments reported in the consolidated balance sheets for current assets and current liabilities approximates their fair values because of the short-term nature of these instruments.

Segment Reporting

Segment Reporting	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Segment Reporting Disclosure	SEGMENT REPORTING Our chief operating decision makers ("CODM") utilize three operating segments, "Acute Care EHR", "Post-acute Care EHR" and "TruBridge", based on our three distinct business units with unique market dynamics and opportunities. Revenues and costs of sales are primarily derived from the provision of services and sales of our proprietary software, and our CODM assess the performance of these three segments at the gross profit level. Operating expenses and items such as interest, income tax, capital expenditures and total assets are managed at a consolidated level and thus are not included in our operating segment disclosures. Our CODM group is comprised of the Chief Executive Officer, Chief Growth Officer, Chief Operating Officer, and Chief Financial Officer. Accounting policies for each of the reportable segments are the same as those used on a consolidated basis. The following table presents a summary of the revenues, cost of sales, and gross profit of our three operating segments for the years ended December 31, 2018, 2017, and 2016: Year Ended December 31, (In thousands) 2018 2017 2016 Revenues: Acute Care EHR Recurring revenue $ 111,936 $ 113,056 $ 117,482 Non-recurring revenue 46,036 51,172 41,664 Total Acute Care EHR revenue 157,972 164,228 159,146 Post-acute Care EHR Recurring revenue 18,599 20,122 20,082 Non-recurring revenue 3,593 3,911 6,437 Total Post-acute Care EHR revenue 22,192 24,033 26,519 TruBridge 100,247 88,666 81,607 Total revenues 280,411 276,927 267,272 Cost of sales: Acute Care EHR 69,831 72,537 78,272 Post-acute Care EHR 6,153 7,481 9,610 TruBridge 54,699 49,636 45,656 Total cost of sales 130,683 129,654 133,538 Gross profit: Acute Care EHR 88,141 91,691 80,874 Post-acute Care EHR 16,039 16,552 16,909 TruBridge 45,548 39,030 35,951 Total gross profit 149,728 147,273 133,734 Corporate operating expenses (124,846) (152,087) (119,359) Other income 803 407 220 Loss on extinguishment of debt — (1,340) — Interest expense (7,577) (7,736) (6,609) Income (loss) before taxes $ 18,108 $ (13,483) $ 7,986

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS Declaration of Dividends On February 15, 2019, the Company announced a dividend for the first quarter of 2019 in the amount of $0.10 per share. The dividend was payable on March 18, 2019 to stockholders of record as of the close of business on March 1, 2019.

Quarterly Financial Statements

Quarterly Financial Statements (Unaudited)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Statements (Unaudited)	QUARTERLY FINANCIAL STATEMENTS (UNAUDITED) The following table presents a summary of our results of operations for our eight most recent quarters ended December 31, 2018. The information for each of these quarters is unaudited and has been prepared on a basis consistent with the audited financial statements. This information includes all adjustments, consisting only of normal recurring adjustments, we consider necessary for fair presentation of this information when read in conjunction with the audited financial statements and related notes. Our operating results have varied on a quarterly basis and may fluctuate significantly in the future. (In thousands, except for per share data) 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Year Ended December 31, 2018 Sales revenues $ 70,882 $ 67,905 $ 69,297 $ 72,327 Gross profit 39,085 34,846 36,113 39,684 Operating income 7,648 2,225 5,361 9,648 Net income 3,967 328 5,749 7,588 Net income per share Basic $ 0.29 $ 0.02 $ 0.41 $ 0.54 Diluted $ 0.29 $ 0.02 $ 0.41 $ 0.54 Year Ended December 31, 2017 Sales revenues $ 64,075 $ 67,677 $ 67,113 $ 78,062 Gross profit 32,700 35,991 34,380 44,202 Operating income (loss) 3,234 4,448 5,622 (18,118) Net income (loss) 246 1,587 2,288 (21,537) Net income (loss) per share Basic $ 0.02 $ 0.11 $ 0.17 $ (1.57) Diluted $ 0.02 $ 0.11 $ 0.17 $ (1.57)

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	VALUATION AND QUALIFYING ACCOUNTS (In thousands) Description Balance at beginning of period Additions charged to cost and expenses (1) Deductions (2) Balance at end of period Allowance for doubtful accounts deducted from accounts receivable in the balance sheet 2016 $ 1,216 $ 497 $ 657 $ 2,370 2017 $ 2,370 $ 1,598 $ (1,314) $ 2,654 2018 $ 2,654 $ 1,485 $ (2,015) $ 2,124 1 Adjustments to allowance for change in estimates. 2 Uncollectible accounts written off, net of recoveries. Description Balance at beginning of period Additions charged to cost and expenses (1) Deductions (2) Balance at end of period Allowance for credit losses deducted from financing receivables in the balance sheet 2016 $ 654 $ 1,762 $ (218) $ 2,198 2017 $ 2,198 $ 1,823 $ (777) $ 3,244 2018 $ 3,244 $ 1,691 $ (2,368) $ 2,567 1 Adjustments to allowance for change in estimates. 2 Uncollectible accounts written off, net of recoveries.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The consolidated financial statements of CPSI include the accounts of TruBridge, LLC ("TruBridge"), Evident, LLC ("Evident"), and Healthland Holding Inc. ("HHI"), all of which are wholly-owned subsidiaries of CPSI. The accounts of HHI include those of its wholly-owned subsidiaries, Healthland Inc. ("Healthland"), Rycan Technologies, Inc. ("Rycan"), and American HealthTech, Inc. ("AHT"). All significant intercompany balances and transactions have been eliminated.
Presentation	Presentation Effective January 1, 2018, our interface services team, which provides the design, development, implementation, and support services for all interfaces for data exchange from the CPSI applications and was previously considered a part of our product development division, has been integrated with our acute care client service team. This transition has worked to create a consistent, personal, and convenient service experience for our clients characterized by transparent communication with prompt resolution. With this change, the payroll and related costs of this group of employees that were formerly included within the caption "Product development" on our consolidated statements of operations are now included within the caption "System sales and support - Cost of sales."
Cash and Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents can include time deposits and certificates of deposit with original maturities of three months or less that are highly liquid and readily convertible to a known amount of cash. These assets are stated at cost, which approximates market value, due to their short duration or liquid nature.
Accounts Receivable and Allowance for Doubtful Accounts	Accounts Receivable and Allowance for Doubtful Accounts Trade accounts receivable are stated at the amount the Company expects to collect and do not bear interest. The Company establishes a general allowance for doubtful accounts based on collections history. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific allowance for doubtful accounts may be recorded to reduce the related receivable to the amount expected to be recovered.
Financing Receivables	Financing Receivables Financing receivables are comprised of short-term payment plans and sales-type leases. Short-term payment plans are stated at the amount the Company expects to collect and do not bear interest. Sales-type leases are initially recorded at the present value of the related minimum lease payments, computed at the interest rate implicit in the lease, and are presented net of unearned income. Unearned income is amortized over the lease term to produce a constant periodic rate of return on the net investment in the lease (the interest method). An allowance for credit losses has been established for our financing receivables based on the historical level of customer defaults under such arrangements. In the case of a bankruptcy filing or other similar event indicating the collectability of specific customer accounts is no longer probable, a specific reserve may be recorded to reduce the related receivable to the amount expected to be recovered. Customer payments are considered past due if a scheduled payment is not received within contractually agreed upon terms, with amounts reclassified to accounts receivable when they become due. As a result, we evaluate the credit quality of our financing receivables on an ongoing basis utilizing an aging of receivables and write-offs, customer collection experience, the customer’s financial condition and known risk characteristics impacting the respective customer base, as well as existing economic conditions, to determine if any further allowance is necessary. Amounts are specifically charged off once all available means of collection have been exhausted.
Inventories	Inventories Inventories are stated at lower of cost or net realizable value using the average cost method. The Company’s inventories are comprised of computer equipment, forms and supplies. For cash flow presentation, inventory used by the Company and capitalized as property and equipment is shown as a change in inventory.
Property and Equipment	Property and Equipment Property and equipment is recorded at cost, less accumulated depreciation. Additions and improvements to property and equipment that materially increase productive capacity or extend the life of an asset are capitalized. Maintenance, repairs and minor renewals are expensed as incurred. Upon retirement or other disposition of such assets, the related costs and accumulated depreciation are removed from the respective accounts and any resulting gain or loss is included in the results of operations. Depreciation expense is computed using the straight-line method over the asset’s useful life, which is generally 5 years for computer equipment, furniture, and fixtures and 30 years for buildings. Leasehold improvements are depreciated over the shorter of the asset’s useful life or the remaining lease term. The Company reviews for the possible impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Depreciation expense is reported in the consolidated statements of operations as a component of costs of sales and operating expenses.
Business Combinations	Business Combinations We apply business combination accounting when we acquire a business. Business combinations are accounted for at fair value. The associated acquisition costs are expensed as incurred and recorded in general and administrative expenses; restructuring costs associated with a business combination are expenses; contingent consideration is measured at fair value at the acquisition date, with changes in fair value after the acquisition date affecting earnings; changes in deferred tax asset valuation allowances and income tax uncertainties after the measurement period affect income tax expense; and goodwill is determined as the excess of the fair value of the consideration conveyed in the acquisition over the fair value of the net assets acquired. The accounting for business combinations requires estimates and judgments as to expectations for future
Goodwill	Goodwill Goodwill is recorded as the difference, if any, between the aggregate consideration paid for an acquisition and the fair value of the identifiable net tangible and intangible assets acquired. Goodwill is not amortized but is evaluated for impairment annually or more frequently if indicators of impairment are present or changes in circumstances suggest that impairment may exist. We test annually for impairment as of October 1. As part of our annual goodwill impairment test, we first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, we conduct a quantitative goodwill impairment assessment. The first step of the quantitative goodwill impairment test compares the fair value of the reporting unit with its carrying amount, including goodwill. The Company early adopted Accounting Standards Update 2017-04 on January 1, 2017, which eliminates the second step of the goodwill impairment analysis. Therefore, if the carrying amount of the reporting unit exceeds its fair value in the first step of the goodwill impairment test, an impairment charge is recognized for the amount by which the carrying amount exceeds the total amount of goodwill allocated to that reporting unit. If the fair value of the reporting unit exceeds its carrying amount, the goodwill of the reporting unit is not considered to be impaired.
Purchased Intangible Assets	Purchased Intangible Assets Purchased intangible assets are acquired in connection with a business acquisition, and are amortized over their estimated useful lives based on the pattern of economic benefit expected from each asset. We concluded for certain purchased intangible assets that the pattern of economic benefit approximated the straight-line method, and therefore, the use of the straight-line method was appropriate, as the majority of the cash flows will be recognized ratably over the estimated useful lives and there is no degradation of the cash flows over time.
Revenue Recognition	Revenue Recognition Revenue is recognized upon transfer of control of promised products or services to clients in an amount that reflects the consideration we expect to receive in exchange for those products and services. We enter into contracts that can include various combinations of products and services, which are generally distinct and accounted for as separate performance obligations. The Company employs the 5-step revenue recognition model under ASC 606 to: (1) identify the contract with the client, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. Revenue is recognized net of shipping charges and any taxes collected from clients, which are subsequently remitted to governmental authorities. • System Sales and Support The Company enters into contractual obligations to sell perpetual software licenses, installation, conversion, and related training services, hardware and software application support, and hardware maintenance services to acute care and post-acute care community hospitals. • Non-recurring Revenues • Perpetual software licenses and installation, conversion, and related training services are not considered separate and distinct performance obligations due to the proprietary nature of our software and are, therefore, accounted for as a single performance obligation on a module-by-module basis. Revenue is recognized as each module's implementation is completed based on the module's stand-alone selling price ("SSP"), net of discounts. Fees for licenses and installation, conversion, and related training services are typically due in three installments: (1) at placement of order, (2) upon installation of software and commencement of training, and (3) upon satisfactory completion of monthly accounting cycle or end-of-month operation by application and as applicable for each application. Often, short-term and/or long-term financing arrangements are provided for software implementations; refer to Note 10 - Financing Receivables for further information. Electronic health records ("EHR") implementations include a system warranty that terminates thirty days from the software go-live date, the date which the client begins using the system in a live environment. • Hardware revenue is recognized separately from software licenses at the point in time it is delivered to the client. The SSP of hardware is cost plus a reasonable margin. Payment is generally due upon delivery of the hardware to the client. Standard manufacturer warranties apply to hardware. • Recurring Revenues • Software application support and hardware maintenance services sold with software licenses and hardware are separate and distinct performance obligations. Revenue for support and maintenance services is recognized based on SSP, which is the renewal price, ratably over the life of the contract, which is generally three to five years. Payment is due monthly for support services provided. • Subscriptions to third -party content revenue is recognized as a separate performance obligation ratably over the subscription term based on SSP, which is cost plus a reasonable margin. Payment is due monthly for subscriptions to third party content. • Software as a Service ("SaaS") arrangements for EHR software and related conversion and training services are considered a single performance obligation. Revenue is recognized on a monthly basis as the SaaS service is provided to the client over the contract term. Payment is due monthly for SaaS services provided. Refer to Note 17 for further information, including revenue by client base (acute care or post-acute care) bifurcated by recurring and non-recurring revenue. • TruBridge TruBridge provides an array of business processing services ("BPS") consisting of accounts receivable management, private pay services, insurance services, medical coding, electronic billing, statement processing, payroll processing, and contract management. Fees are recognized over the period of the client contractual relationship as the services are performed based on the SSP, net of discounts. Fees for many of these services are invoiced, and revenue recognized accordingly, based on the volume of transactions or a percentage of client accounts receivable collections. Payment is due monthly for BPS with certain amounts varying based on utilization and/or volumes. TruBridge also provides professional IT services. Revenue from professional IT services is recognized as the services are performed based on SSP. Payment is due monthly as services are performed. • Deferred Revenue Deferred revenue represents amounts invoiced to clients for which the services under contract have not been completed and revenue has not been recognized, including annual renewals of certain software subscriptions and customer deposits for implementations to be performed at a later date. Revenue is recognized ratably over the life of the software subscriptions as services are provided and at the point-in-time when implementations have been completed. (In thousands) For Year Ended December 31, 2018 Balance as of January 1, 2018 $ 9,937 Deferred revenue recorded 19,818 Less deferred revenue recognized as revenue (19,554) Balance as of December 31, 2018 $ 10,201 The deferred revenue recorded during the year December 31, 2018 is comprised primarily of the annual renewals of certain software subscriptions billed during the year and deposits collected for future EHR installations. The deferred revenue recognized as revenue during 2018 is comprised primarily of the periodic recognition of annual renewals that were deferred until earned and deposits for future EHR installations that were deferred until earned. • Costs to Obtain and Fulfill a Contract with a Customer Costs to obtain a contract include the commission costs related to SaaS arrangements, which are capitalized and amortized ratably over the expected life of the customer. As a practical expedient, we generally recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset would have been one year or less, with the exception of commissions generated from TruBridge sales. TruBridge commissions, which are paid up to twelve months in advance, are capitalized and amortized over the prepayment period. Costs to obtain a contract are expensed within sales and marketing expenses in the accompanying consolidated statements of operations. Contract fulfillment costs related to the implementation of SaaS arrangements are capitalized and amortized ratably over the expected life of the customer. Costs to fulfill contracts consist of the payroll costs for the implementation of SaaS arrangements, including time for training, conversion, and installation that is necessary for the software to be utilized. Contract fulfillment costs are expensed within the caption "System sales and support - Cost of sales" in the accompanying consolidated statements of operations. Costs to obtain and fulfill contracts related to SaaS arrangements are included within the "Prepaid expenses and other" and "Other assets, net of current portion" line items on our consolidated balance sheets. (In thousands) For Year Ended December 31, 2018 Balance as of January 1, 2018 $ 3,775 Costs to obtain and fulfill contracts capitalized 3,345 Less costs to obtain and fulfill contracts recognized as expense (4,103) Balance as of December 31, 2018 $ 3,017 • Significant Judgments Our contracts with clients often include promises to transfer multiple products and services. Determining whether products and services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Judgment is required to determine SSP for each distinct performance obligation. We use observable SSP for items that are sold on a stand-alone basis to similarly situated clients at unit prices within a sufficiently narrow range. For performance obligations that are sold to different clients for a broad range of amounts, or for performance obligations that are never sold on a stand-alone basis, the residual method in determining SSP is applied and requires significant judgment. Allocating the transaction price, including estimating SSP of promised goods and services for contracts with discounts or variable consideration, may require significant judgment. Due to the short time frame of the implementation cycle, discount allocation is immaterial as revenue is recognized net of discounts within the same reporting period. In scenarios where the Company enters into a contract that includes both a software license and BPS or other services that are charged based on volume of services rendered, the Company allocates variable amounts entirely to a distinct good or service. The terms of the variable payment relate specifically to the entity’s efforts to satisfy that performance obligation. Significant judgment is required in determining the expected life of a customer, which is the amortization period for costs to obtain and fulfill a contract that have been capitalized. The Company determined that the expected life of the customer is not materially different from the initial contract term based on the characteristics of the SaaS offering. • Remaining Performance Obligations Disclosures regarding remaining performance obligations are not considered material as the overwhelming majority of the Company's remaining performance obligations either (a) are related to contracts with an expected duration of one year or less, or (b) exhibit revenue recognition in the amount to which the Company has the right to invoice.
Stock-Based Compensation	Stock-Based Compensation The Company accounts for stock-based compensation according to the provisions of FASB Codification topic, Compensation – Stock Compensation, which establishes accounting for stock-based awards exchanged for employee services. Accordingly, stock-based compensation cost is measured at the grant date based on the fair value of the award, and is recognized as an expense over the employee’s or non-employee director’s requisite service period.
Product Development Costs	Product Development CostsProduct development costs are expensed as incurred. Product development costs totaled approximately $36.4 million, $33.7 million, and $29.1 million for the years ended December 31, 2018, 2017 and 2016, respectively.
Income Taxes	Income Taxes We account for income taxes in accordance with FASB Codification topic, Income Taxes . Under this topic, deferred income taxes are determined utilizing the asset and liability approach. This method gives consideration to the future tax consequences associated with differences between financial accounting and tax bases of assets and liabilities. The effect on the deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We recognize interest and penalties accrued related to unrecognized tax benefits in the consolidated statements of operations as a component of the provision for income taxes. We also make a provision for uncertain income tax positions in accordance with the Income Taxes Codification topic. These provisions require that a tax position taken in a tax return be recognized in the financial statements when it is more likely than not (i.e., a likelihood of more than fifty percent) that the position would be sustained upon examination by tax authorities. A recognized tax position is then measured at the largest amount of benefit that is greater than fifty percent likely of being realized upon settlement. The topic also requires that changes in judgment that result in subsequent recognition, derecognition, or change in a measurement date of a tax position taken in a prior annual period (including any related interest and penalties) be recognized as a discrete item in the interim period in which the change occurs.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported revenues and expenses during the reporting periods. Actual results could differ from those estimates.
Segment Reporting	Segment ReportingOperating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, which we refer to as the CODM, or decision-making group in assessing performance and making decisions regarding resource allocation. The Company has prepared operating segment information based on the manner in which management disaggregates the Company's operations for making internal operating decisions.
New Accounting Standards Adopted in 2018	New Accounting Standards Adopted in 2018 In May 2014, the Financial Accounting Standards Board ("FASB") issued ASU 2014-09, Revenue from Contracts with Customers , to clarify the principles for recognizing revenue and to develop a common revenue standard for U.S. GAAP and International Financial Reporting Standards. The standard outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes prior revenue recognition guidance. This guidance was effective for fiscal years and interim periods within those years beginning after December 15, 2017, which was effective for the Company as of the first quarter of our fiscal year ended December 31, 2018. We adopted this new accounting standard codified as Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers , and the related amendments (the "new revenue standard") during the first quarter of 2018 and have applied it to all contracts using the modified retrospective method, pursuant to which the cumulative effect of initially applying the new revenue standard is recognized as an adjustment to retained earnings and impacted balance sheet line items as of January 1, 2018, the date of adoption. The comparative previous period information continues to be reported under the accounting standards in effect for that period. We completed an assessment of our systems, data, and processes that are affected by the implementation of this new revenue standard and have concluded that this standard does not significantly alter revenue recognition practices for our system sales and support and TruBridge revenue streams. The impact on our revenue recognition is limited to deferring and amortizing implementation fees over the contract life related to our Rycan revenue cycle management product, in which we previously recognized revenue as implementation was completed. Rycan implementation fees totaled $1.6 million in 2017, less than 1% of our 2017 revenues. The balance sheet impact of the deferred revenue related to these fees was an increase of $1.8 million as of the date of adoption. Also impacting deferred revenue was a decrease of $0.6 million related to previous billings which no longer required deferred recognition as of the date of adoption. In addition to revenue recognition, the new revenue standard impacts our consolidated financial statements with respect to the capitalization of certain commissions and contract fulfillment costs which were previously expensed as incurred. Commissions and contract fulfillment costs related to the implementation of software as a service arrangements are now capitalized and amortized over the expected life of the customer. TruBridge commissions, which are paid up to twelve months in advance, are now capitalized and amortized over the prepayment period. The balance sheet impact of the prepaid assets was an increase of $3.8 million as of the date of adoption. Due to the aforementioned changes in assets and liabilities related to the adoption of the new revenue standard, our deferred tax liability increased $0.6 million as of the date of adoption. In total, the adoption of ASU 2014-09 resulted in a net increase in retained earnings of $2.0 million as of the date of adoption. In accordance with the new revenue standard requirements, the disclosures of the impact of adoption on our consolidated statement of operations and balance sheet were as follows: For Year Ended December 31, 2018 (In thousands) As reported Balances without adoption of ASC 606 Effect of adoption increase/(decrease) Consolidated Statements of Operations Revenue: TruBridge $ 100,247 $ 100,264 $ (17) Cost of sales: System sales and support 75,984 75,857 127 Gross profit 149,728 149,872 (144) Sales and marketing 30,713 30,083 630 Operating income 24,882 25,656 (774) Provision for income taxes 476 638 (162) Net income $ 17,632 $ 18,244 $ (612) December 31, 2018 (In thousands) As reported Balances without adoption of ASC 606 Effect of adoption increase/(decrease) Consolidated Balance Sheet Prepaid assets and other $ 5,055 $ 3,032 $ 2,023 Other assets, net of current 995 — 995 Total assets 327,746 324,728 3,018 Deferred revenue 10,201 8,953 1,248 Deferred tax liability 4,877 4,466 411 Total liabilities 167,963 166,304 1,659 Accumulated deficit $ (5,024) $ (6,383) $ 1,359 The effects of the changes in balance sheet accounts resulting from the adoption of the new revenue standard are primarily due to the beginning adjustments for adoption mentioned above, accompanied by incremental changes resulting from activity during the period ended December 31, 2018. The new revenue standard requirements did not impact our net cash provided by or used in operating, investing, or financing cash flows on our consolidated statements of cash flows, although components within changes in operating assets and liabilities were immaterially impacted by adoption. In August 2016, the FASB issued ASU 2016-15, Classifications of Certain Cash Receipts and Cash Payments, which clarifies cash flow classification for eight specific issues, including debt prepayment or extinguishment costs, contingent consideration payments made after a business combination, proceeds from the settlement of insurance claims, and proceeds from the settlement of corporate-owned life insurance policies. This guidance was effective for fiscal years and interim periods within those years beginning after December 15, 2017, which was effective for the Company as of the first quarter of our fiscal year ended December 31, 2018. The adoption of ASU 2016-15 did not have a material effect on our financial statements. In January 2017, the FASB issued ASU 2017-01, Clarifying the Definition of a Business, to assist an entity in evaluating when a set of transferred assets and activities is a business. The guidance was effective for fiscal years and interim periods within those years beginning after December 15, 2017, and will be applied prospectively to any transactions occurring following adoption. The adoption of ASU 2017-01 did not have a material effect on our financial statements.
Net Income Per Share	The Company presents basic and diluted earnings per share ("EPS") data for its common stock. Basic EPS is calculated by dividing the net income attributable to stockholders of the Company by the weighted average number of shares of common stock outstanding during the period. Diluted EPS is determined by adjusting the net income attributable to stockholders of the Company and the weighted average number of shares of common stock outstanding during the period for the effects of all dilutive potential common shares, including awards under stock-based compensation arrangements. The Company's unvested restricted stock awards (see Note 8) are considered participating securities under FASB Codification topic, Earnings Per Share , because they entitle holders to non-forfeitable rights to dividends until the awards vest or are forfeited. When a company has a security that qualifies as a "participating security," the Codification requires the use of the two-class method when computing basic EPS. The two-class method is an earnings allocation formula that determines EPS for each class of common stock and participating security according to dividends declared (or accumulated) and participation rights in undistributed earnings. In determining the amount of net income to allocate to common stockholders, income is allocated to both common stock and participating securities based on their respective weighted average shares outstanding for the period, with net income attributable to common stockholders ultimately equaling net income less net income attributable to participating securities. Diluted EPS for the Company's common stock is computed using the more dilutive of the two-class method or the treasury stock method.
Fair Value	FASB Codification topic, Fair Value Measurements and Disclosures, establishes a framework for measuring fair value and expands financial statement disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Codification topic does not require any new fair value measurements, but rather applies to all other accounting pronouncements that require or permit fair value measurements. The Codification topic requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs that are not corroborated by market data.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Schedule of Amounts Reclassified	Amounts presented for the years ended December 31, 2017 and 2016, have been reclassified to conform to the current presentation. The following table provides the amounts reclassified for the year ended December 31, 2017: (In thousands) As previously reported Reclassifications As reclassified Costs of sales: System sales and support $ 75,994 4,024 $ 80,018 Operating expenses: Product development $ 37,761 (4,024) $ 33,737 The following table provides the amounts reclassified for the year ended December 31, 2016: (In thousands) As previously reported Reclassifications As reclassified Costs of sales: System sales and support $ 84,356 3,526 $ 87,882 Operating expenses: Product development $ 32,621 (3,526) $ 29,095
Schedule of Contract with Customer, Asset and Liability	(In thousands) For Year Ended December 31, 2018 Balance as of January 1, 2018 $ 9,937 Deferred revenue recorded 19,818 Less deferred revenue recognized as revenue (19,554) Balance as of December 31, 2018 $ 10,201
Schedule of Changes in Capitalized Contract Cost	Costs to obtain and fulfill contracts related to SaaS arrangements are included within the "Prepaid expenses and other" and "Other assets, net of current portion" line items on our consolidated balance sheets. (In thousands) For Year Ended December 31, 2018 Balance as of January 1, 2018 $ 3,775 Costs to obtain and fulfill contracts capitalized 3,345 Less costs to obtain and fulfill contracts recognized as expense (4,103) Balance as of December 31, 2018 $ 3,017
Schedule of New Accounting Pronouncements and Changes in Accounting Principle	In accordance with the new revenue standard requirements, the disclosures of the impact of adoption on our consolidated statement of operations and balance sheet were as follows: For Year Ended December 31, 2018 (In thousands) As reported Balances without adoption of ASC 606 Effect of adoption increase/(decrease) Consolidated Statements of Operations Revenue: TruBridge $ 100,247 $ 100,264 $ (17) Cost of sales: System sales and support 75,984 75,857 127 Gross profit 149,728 149,872 (144) Sales and marketing 30,713 30,083 630 Operating income 24,882 25,656 (774) Provision for income taxes 476 638 (162) Net income $ 17,632 $ 18,244 $ (612) December 31, 2018 (In thousands) As reported Balances without adoption of ASC 606 Effect of adoption increase/(decrease) Consolidated Balance Sheet Prepaid assets and other $ 5,055 $ 3,032 $ 2,023 Other assets, net of current 995 — 995 Total assets 327,746 324,728 3,018 Deferred revenue 10,201 8,953 1,248 Deferred tax liability 4,877 4,466 411 Total liabilities 167,963 166,304 1,659 Accumulated deficit $ (5,024) $ (6,383) $ 1,359

Business Combination (Tables)

Business Combination (Tables)	12 Months Ended
	Dec. 31, 2018
Business Acquisition [Line Items]
Allocation of Purchase Price	(In thousands) Purchase Price Cash consideration, net of acquired cash received $ 162,611 Fair value of common stock and options issued as consideration 97,017 Total consideration $ 259,628
Pro Forma Results on Income	The following unaudited pro forma revenue, net income and earnings per share amounts for the year ended December 31, 2016 gives effect to the HHI acquisition as if it had been completed on January 1, 2015. The pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of what the operating results actually would have been during the periods presented had the HHI acquisition been completed during the periods presented. In addition, the unaudited pro forma financial information does not purport to project future operating results. The pro forma information does not fully reflect: (1) any anticipated synergies (or costs to achieve synergies) or (2) the impact of non-recurring items directly related to the HHI acquisition. Year Ended December 31, (In thousands, except per share data, unaudited) 2016 Pro forma revenues $ 270,974 Pro forma net income $ 8,538 Pro forma diluted earnings per share $ .64
Healthland Holding, Inc.
Business Acquisition [Line Items]
Allocation of Purchase Price	The allocation of the purchase price paid for HHI was as follows: (In thousands) Purchase Price Allocation Acquired cash $ 5,371 Accounts receivable 5,789 Financing receivables 2,184 Inventories 216 Prepaid expenses 3,228 Property and equipment 1,263 Intangible assets 117,300 Goodwill 168,449 Accounts payable and accrued liabilities (17,490) Deferred taxes, net (4,010) Contingent consideration (1,620) Deferred revenue (15,681) Net assets acquired $ 264,999

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2018
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment were comprised of the following at December 31, 2018 and 2017: (In thousands) 2018 2017 Land $ 2,848 $ 2,848 Buildings and improvements 7,752 8,240 Computer equipment 2,766 3,245 Leasehold improvements 1,198 5,001 Office furniture and fixtures 1,938 2,462 Automobiles 18 70 16,520 21,866 Less: accumulated depreciation (5,645) (10,174) Property and equipment, net $ 10,875 $ 11,692

Other Accrued Liabilities (Tabl

Other Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2018
Payables and Accruals [Abstract]
Schedule of Other Accrued Liabilities	Other accrued liabilities were comprised of the following at December 31, 2018 and 2017: (In thousands) 2018 2017 Salaries and benefits $ 8,722 $ 8,432 Severance 992 1,139 Commissions 830 2,416 Self-insurance reserves 1,017 1,024 Contingent consideration 206 586 Other 452 501 Other accrued liabilities $ 12,219 $ 14,098

Net Income Per Share (Tables)

Net Income Per Share (Tables)	12 Months Ended
	Dec. 31, 2018
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following is a calculation of the basic and diluted EPS for the Company's common stock, including a reconciliation between net income (loss) and net income (loss) attributable to common stockholders for the years ended December 31, 2018, 2017, and 2016: (In thousands, except for per share data) 2018 2017 2016 Basic EPS Numerator Net income (loss) $ 17,632 $ (17,416) $ 3,933 Less: Net (income) loss attributable to participating securities (595) 316 (38) Net income (loss) attributable to common stockholders $ 17,037 $ (17,100) $ 3,895 Denominator Weighted average shares outstanding used in basic per common share computations 13,561 13,419 13,255 Basic EPS $ 1.26 $ (1.27) $ .29 Diluted EPS Numerator Net income (loss) attributable to common stockholders $ 17,037 $ (17,100) $ 3,895 Reallocation of net income (loss) attributable to participating securities — — — Net income (loss) attributable to common stockholders for diluted EPS $ 17,037 $ (17,100) $ 3,895 Denominator Weighted average shares outstanding used in basic per common share computations 13,561 13,419 13,255 Weighted average effect of dilutive securities: Performance share awards 7 — — Weighted average shares outstanding used in diluted per common share computations 13,568 13,419 13,255 Diluted EPS $ 1.26 $ (1.27) $ .29

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Deferred Tax Assets and Liabilities	Deferred tax assets and liabilities were comprised of the following at December 31, 2018 and 2017: (In thousands) 2018 2017 Deferred tax assets: Accounts receivable and financing receivables $ 1,112 $ 1,395 Accrued vacation 529 519 Stock-based compensation 2,264 1,416 Deferred revenue 250 132 Accrued severance 173 207 Accrued liabilities and other — 884 Fixed assets — 172 Credits 1,984 — Net operating loss 10,347 13,261 Deferred tax assets 16,659 17,986 Less: Valuation allowance 456 1,605 Total deferred tax assets $ 16,203 $ 16,381 Deferred tax liabilities: Intangible assets $ 19,957 $ 21,048 Accrued liabilities and other 897 — Fixed assets 226 — Total deferred tax liabilities $ 21,080 $ 21,048 Total net deferred tax liability $ (4,877) $ (4,667)
Components of Income Tax Provision	Significant components of the income tax provision for the years ended December 31, 2018, 2017 and 2016 were as follows: (In thousands) 2018 2017 2016 Current provision: Federal $ (594) $ 1,535 $ (72) State 1,434 977 453 Deferred provision: Federal 649 1,070 4,144 State (1,013) 351 (472) Total income tax provision $ 476 $ 3,933 $ 4,053
Reconciliation to Federal Statutory Income Tax Rate	The difference between income taxes at the U.S. federal statutory income tax rate of 21% for year ended December 31, 2018, and 35% for years ended December 31, 2017 and 2016, and those reported in the consolidated statements of operations for the years ended December 31, 2018, 2017 and 2016 are as follows: (In thousands) 2018 2017 2016 Income taxes at U.S. federal statutory rate $ 3,803 $ (4,584) $ 2,795 Provision-to-return adjustments (112) 433 325 State income tax, net of federal tax effect 1,109 458 5 Domestic production activities deduction — (280) — Tax credits (3,428) (393) (349) Transaction costs — — 1,312 Goodwill impairment — 9,520 — Stock-based compensation 356 1,155 — Deferred impact of tax reform — (1,890) — Change in valuation allowance (1,149) (304) — Other (103) (182) (35) Total income tax provision $ 476 $ 3,933 $ 4,053

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Stock-Based Compensation Expense	The following table details total stock-based compensation expense for the years ended December 31, 2018, 2017 and 2016, included in the consolidated statements of operations: (In thousands) 2018 2017 2016 Costs of sales $ 2,134 $ 1,750 $ 1,396 Operating expenses 7,581 5,416 3,970 Pre-tax stock-based compensation expense 9,715 7,166 5,366 Less: income tax effect (2,040) (2,795) (2,093) Net (after tax) stock-based compensation expense $ 7,675 $ 4,371 $ 3,273
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Activity Under Restricted Stock Plans	years ended December 31, 2018, 2017 and 2016 is as follows: Shares Weighted-Average Grant-Date Fair Value Nonvested stock outstanding at January 1, 2016 191,397 $ 57.12 Granted 86,984 52.21 Vested (93,496) 57.48 Nonvested stock outstanding at December 31, 2016 184,885 $ 54.63 Granted 225,954 32.79 Vested (101,644) 55.58 Nonvested stock outstanding at December 31, 2017 309,195 $ 38.36 Granted 148,841 30.20 Performance share awards converted to restricted stock 177,395 29.94 Vested (156,988) 40.52 Forfeited (3,311) 30.20 Nonvested stock outstanding at December 31, 2018 475,132 $ 32.00
Performance shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of Activity Under Restricted Stock Plans	A summary of performance share award activity under the 2014 Incentive Plan for the years ended December 31, 2018, 2017 and 2016, is as follows, based on the target award amounts set forth in the performance share award agreements: Shares Weighted-Average Grant-Date Fair Value Performance share awards outstanding at January 1, 2016 49,471 $ 49.29 Granted 77,594 49.64 Forfeited or unearned (49,471) 49.29 Performance share awards outstanding at December 31, 2016 77,594 $ 49.64 Granted 189,325 29.94 Forfeited or unearned (77,594) 49.64 Performance share awards outstanding at December 31, 2017 189,325 $ 29.94 Granted 184,776 30.15 Forfeited or unearned (11,930) 29.94 Performance share awards converted to restricted stock (177,395) 29.94 Performance share awards outstanding at December 31, 2018 184,776 $ 30.15

Financing Receivables (Tables)

Financing Receivables (Tables)	12 Months Ended
	Dec. 31, 2018
Receivables [Abstract]
Components of Short-Term Payment Plans	These receivables, included in the current portion of financing receivables, were comprised of the following on December 31, 2018 and 2017: (In thousands) 2018 2017 Short-term payment plans, gross $ 5,773 $ 9,081 Less: allowance for losses (404) (638) Short-term payment plans, net $ 5,369 $ 8,443
Components of Lease Receivables	The components of these receivables were as follows on December 31: (In thousands) 2018 2017 Long-term financing arrangements, gross $ 34,841 $ 22,968 Less: allowance for losses (2,163) (2,606) Less: unearned income (3,725) (2,265) Long-term financing arrangements, net $ 28,953 $ 18,097
Future Minimum Lease Payments to be Received	Future minimum payments to be received subsequent to December 31, 2018 are as follows: (In thousands) 2019 $ 10,825 2020 9,098 2021 6,942 2022 4,792 2023 2,423 Thereafter 761 Total minimum payments to be received 34,841 Less: allowance for losses (2,163) Less: unearned income (3,725) Receivables, net $ 28,953
Roll-Forward of Allowance for Financing Credit Losses	The following table is a roll-forward of the allowance for financing credit losses for the years ended December 31, 2018 and 2017: (In thousands) Beginning Balance Provision Charge-offs Recoveries Ending Balance December 31, 2018 $ 3,244 $ 1,691 $ (2,368) $ — $ 2,567 December 31, 2017 $ 2,198 $ 1,823 $ (777) $ — $ 3,244
Analysis of Age of Financing Receivables Amounts	The following is an analysis of the age of financing receivables amounts (excluding short-term payment plans) that have been reclassified to trade accounts receivable and were past due as of December 31, 2018 and December 31, 2017: (In thousands) 1 to 90 Days Past Due 91 to 180 Days Past Due 181 + Days Past Due Total Past Due December 31, 2018 $ 1,302 $ 210 $ 245 $ 1,757 December 31, 2017 $ 980 $ 171 $ — $ 1,151
Categories of Customer Financing Receivables	The table below categorizes customer financing receivable balances (excluding short term payment plans), none of which are considered past due, based on the age of the oldest payment outstanding that has been reclassified to trade accounts receivable: (In thousands) December 31, 2018 December 31, 2017 Stratification of uninvoiced client financing receivables based on aging of related trade accounts receivable: 1 to 90 Days Past Due $ 17,290 $ 11,300 91 to 180 Days Past Due 2,247 3,727 181+ Days Past Due 885 967 Total uninvoiced client financing receivables balances of clients with a trade accounts receivable $ 20,422 $ 15,994 Total uninvoiced client financing receivables of clients with no related trade accounts receivable 10,694 4,709 Total financing receivables with contractual maturities of one year or less 5,773 9,081 Less: allowance for losses (2,567) (3,244) Total financing receivables $ 34,322 $ 26,540

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Definite-Lived Intangible Assets	Our purchased definite-lived intangible assets as of December 31, 2018 and 2017 are summarized as follows: (In thousands) Customer Relationships Trademark Developed Technology Total Gross carrying amount $ 82,300 $ 10,900 $ 24,100 $ 117,300 Accumulated amortization as of December 31, 2017 (12,937) (1,682) (5,968) (20,587) Net intangible assets as of December 31, 2017 69,363 9,218 18,132 96,713 Amortization expenses for year ended December 31, 2018 (6,539) (931) (3,017) (10,487) Net intangible assets as of December 31, 2018 $ 62,824 $ 8,287 $ 15,115 $ 86,226 Weighted average remaining years of useful life 10 12 5 9
Schedule of Remaining Amortization of Definite-Lived Intangible Assets	The following table represents the remaining amortization of definite-lived intangible assets as of December 31, 2018: (In thousands) For the year ended December 31, 2019 $ 10,072 2020 10,066 2021 10,066 2022 10,066 2023 10,066 Due thereafter 35,890 Total $ 86,226
Schedule of Changes in the Carrying Amount of Goodwill	The following table sets forth the change in the carrying amount of goodwill by segment for the years ended December 31, 2018, 2017, and 2016: (In thousands) Acute Care EHR Post-acute Care EHR TruBridge Total Balance as of December 31, 2015 $ — $ — $ — $ — Goodwill acquired 97,095 57,570 13,784 168,449 Balance as of December 31, 2016 97,095 57,570 13,784 168,449 Goodwill impairment — (28,000) — (28,000) Balance as of December 31, 2017 and 2018 $ 97,095 $ 29,570 $ 13,784 $ 140,449

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	Long-term debt was comprised of the following at December 31, 2018 and 2017: (In thousands) December 31, 2018 December 31, 2017 Term loan facility $ 102,432 115,538 Revolving credit facility 29,693 27,983 Capital lease obligation 250 565 Debt obligations 132,375 144,086 Less: debt issuance costs (1,306) (1,652) Debt obligation, net 131,069 142,434 Less: current portion (6,486) (5,820) Long-term debt $ 124,583 $ 136,614
Schedule of Anticipated Annual Future Maturities	Anticipated annual future maturities of the term loan facility, revolving credit facility, and capital lease obligation are as follows as of December 31, 2018: (In thousands) 2019 $ 6,831 2020 8,775 2021 9,506 2022 107,263 Thereafter — $ 132,375 Our credit facilities are secured pursuant to a Pledge and Security Agreement, dated January 8, 2016, among the parties identified as obligors therein and Regions, as collateral agent, on a first priority basis by a security interest in substantially all of the tangible and intangible assets (subject to certain exceptions) of the Company and certain subsidiaries of the Company, as guarantors (collectively, the “Subsidiary Guarantors”), including certain registered intellectual property and the capital stock of certain of the Company’s direct and indirect subsidiaries. Our obligations under the credit agreement are also guaranteed by the Subsidiary Guarantors. The credit agreement, as amended by the Third Amendment, provides incremental facility capacity of $50 million, subject to certain conditions. The credit agreement includes a number of restrictive covenants that, among other things and in each case subject to certain exceptions and baskets, impose operating and financial restrictions on the Company and the Subsidiary Guarantors, including the ability to incur additional debt; incur liens and encumbrances; make certain restricted payments, including paying dividends on the Company's equity securities or payments to redeem, repurchase or retire the Company's equity securities (which are subject to our compliance, on a pro forma basis to give effect to the restricted payment, with the fixed charge coverage ratio and consolidated leverage ratio described below); enter into certain restrictive agreements; make investments, loans and acquisitions; merge or consolidate with any other person; dispose of assets; enter into sale and leaseback transactions; engage in transactions with affiliates; and materially alter the business we conduct. The credit agreement requires the Company to maintain a minimum fixed charge coverage ratio of 1.25:1.00 throughout the duration of such agreement. Under the credit agreement, the Company is required to comply with a maximum consolidated leverage ratio of 3.95:1.00 through December 31, 2017 and 3.50:1.00 from January 1, 2018 and thereafter. The credit agreement also contains customary representations and warranties, affirmative covenants and events of default. We believe that we were in compliance with the covenants contained in the credit agreement as of December 31, 2018. The dividend restriction in the credit agreement provides that no dividends may be paid unless there is no existing default, the dividend will not cause the Company to be out of compliance with the Company’s debt covenants, and as of any date of determination, the aggregate amount of dividends and other distributions made by the Company in any specified period (including the dividend or distribution to be paid on such date) shall not exceed the lesser of (A) the aggregate amount of the Company’s publicly announced dividend policy in effect for each fiscal quarter for the period of four full fiscal quarters most recently ended prior to such date or (B) 70% of the non-GAAP earnings per share for the period of four full fiscal quarters most recently ended prior to such date, calculated by the Company in good faith, in a manner consistent with past practices. For purposes of this restriction, “specified period” means, the period (x) commencing on the first day of the three full fiscal quarter period most recently ended prior to such date through (y) such date of determination. As of December 31, 2018, the Company had the capacity under the credit agreement to pay up to $18.3 million in additional dividends. The credit agreement requires the Company to mandatorily prepay our credit facilities with (i) 75% of excess cash flow (minus certain specified other payments) during each of the fiscal years ending December 31, 2017 and December 31, 2018 and (ii) 50% of excess cash flow (minus certain specified other payments) during the fiscal year ending December 31, 2019 and thereafter. The Company is permitted to voluntarily prepay our credit facilities at any time without penalty, subject to customary “breakage” costs with respect to prepayments of LIBOR rate loans made on a day other than the last day of any applicable interest period. The excess cash flow mandatory prepayment requirement under the credit agreement resulted in a $7.3 million prepayment on the term loan facility during the first quarter of 2018 related to excess cash flow generated by the Company during 2017. This mandatory prepayment was funded by drawing down on the revolving credit facility, as excess cash flow generated by the Company during 2017 was primarily used to voluntarily prepay amounts due under the revolving credit facility.

Operating Leases (Tables)

Operating Leases (Tables)	12 Months Ended
	Dec. 31, 2018
Leases [Abstract]
Future Minimum Lease Payments	The future minimum lease payments payable under these operating leases subsequent to December 31, 2018 are as follows: (In thousands) 2019 $ 1,482 2020 997 2021 960 2022 887 2023 844 Thereafter 2,515 $ 7,685

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Carrying Amounts and Fair Values of Certain Assets	Fair Value at December 31, 2018 Using Quoted Prices in Carrying Active Markets for Significant Other Significant Amount at Identical Assets Observable Inputs Unobservable Inputs (In thousands) 12/31/2018 (Level 1) (Level 2) (Level 3) Description Contingent consideration $ 206 $ — $ — $ 206 Total $ 206 $ — $ — $ 206 The following table summarizes the carrying amounts and fair values of certain assets at December 31, 2017: Fair Value at December 31, 2017 Using Quoted Prices in Carrying Active Markets for Significant Other Significant Amount at Identical Assets Observable Inputs Unobservable Inputs (In thousands) 12/31/2017 (Level 1) (Level 2) (Level 3) Description Contingent consideration $ 586 $ — $ — $ 586 Total $ 586 $ — $ — $ 586

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Dec. 31, 2018
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment	The following table presents a summary of the revenues, cost of sales, and gross profit of our three operating segments for the years ended December 31, 2018, 2017, and 2016: Year Ended December 31, (In thousands) 2018 2017 2016 Revenues: Acute Care EHR Recurring revenue $ 111,936 $ 113,056 $ 117,482 Non-recurring revenue 46,036 51,172 41,664 Total Acute Care EHR revenue 157,972 164,228 159,146 Post-acute Care EHR Recurring revenue 18,599 20,122 20,082 Non-recurring revenue 3,593 3,911 6,437 Total Post-acute Care EHR revenue 22,192 24,033 26,519 TruBridge 100,247 88,666 81,607 Total revenues 280,411 276,927 267,272 Cost of sales: Acute Care EHR 69,831 72,537 78,272 Post-acute Care EHR 6,153 7,481 9,610 TruBridge 54,699 49,636 45,656 Total cost of sales 130,683 129,654 133,538 Gross profit: Acute Care EHR 88,141 91,691 80,874 Post-acute Care EHR 16,039 16,552 16,909 TruBridge 45,548 39,030 35,951 Total gross profit 149,728 147,273 133,734 Corporate operating expenses (124,846) (152,087) (119,359) Other income 803 407 220 Loss on extinguishment of debt — (1,340) — Interest expense (7,577) (7,736) (6,609) Income (loss) before taxes $ 18,108 $ (13,483) $ 7,986

Quarterly Financial Statement_2

Quarterly Financial Statements (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Statements	(In thousands, except for per share data) 1st Quarter 2nd Quarter 3rd Quarter 4th Quarter Year Ended December 31, 2018 Sales revenues $ 70,882 $ 67,905 $ 69,297 $ 72,327 Gross profit 39,085 34,846 36,113 39,684 Operating income 7,648 2,225 5,361 9,648 Net income 3,967 328 5,749 7,588 Net income per share Basic $ 0.29 $ 0.02 $ 0.41 $ 0.54 Diluted $ 0.29 $ 0.02 $ 0.41 $ 0.54 Year Ended December 31, 2017 Sales revenues $ 64,075 $ 67,677 $ 67,113 $ 78,062 Gross profit 32,700 35,991 34,380 44,202 Operating income (loss) 3,234 4,448 5,622 (18,118) Net income (loss) 246 1,587 2,288 (21,537) Net income (loss) per share Basic $ 0.02 $ 0.11 $ 0.17 $ (1.57) Diluted $ 0.02 $ 0.11 $ 0.17 $ (1.57)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Reclassifications (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Costs of sales:
System sales and support	$ 75,984	$ 80,018	$ 87,882
Operating expenses:
Product development	$ 36,371	33,737	29,095
As previously reported
Costs of sales:
System sales and support		75,994	84,356
Operating expenses:
Product development		37,761	32,621
Reclassifications
Costs of sales:
System sales and support		4,024	3,526
Operating expenses:
Product development		$ (4,024)	$ (3,526)

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Computer equipment
Property, Plant and Equipment [Line Items]
Useful life		5 years
Office furniture and fixtures
Property, Plant and Equipment [Line Items]
Useful life	5 years
Buildings
Property, Plant and Equipment [Line Items]
Useful life	30 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Revenue Recognition (Details)	12 Months Ended
	Dec. 31, 2018
Minimum
Revenue from External Customer [Line Items]
Support and maintenance revenue recognition period	3 years
Maximum
Revenue from External Customer [Line Items]
Support and maintenance revenue recognition period	5 years

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Other Narrative (Details) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 01, 2019	Jan. 01, 2018
Accounting Policies [Abstract]
Product development costs									$ 36,371,000	$ 33,737,000	$ 29,095,000
Goodwill [Line Items]
Goodwill impairment									0	28,000,000	0
Sales revenues:	$ 72,327,000	$ 69,297,000	$ 67,905,000	$ 70,882,000	$ 78,062,000	$ 67,113,000	$ 67,677,000	$ 64,075,000	280,411,000	276,927,000	267,272,000
Deferred revenue	10,201,000				9,937,000				10,201,000	9,937,000
Deferred revenue no longer deferred									(19,554,000)
Deferred tax liabilities	4,877,000				4,667,000				4,877,000	4,667,000
Retained earnings	(5,024,000)				(19,006,000)				(5,024,000)	(19,006,000)
Total costs of sales									130,683,000	129,654,000	133,538,000
Capital lease obligation	250,000				565,000				250,000	565,000
ASU 2014-09 | Difference between revenue guidance in effect before and after Topic 606
Goodwill [Line Items]
Sales revenues:										$ 1,600,000
Implementation fee revenue as a percentage of total revenue (less than)										1.00%
Deferred revenue	1,800,000								1,800,000
Deferred revenue no longer deferred									600,000
Prepaid assets	3,800,000								3,800,000
Deferred tax liabilities	411,000								411,000				$ 600,000
Retained earnings	$ 1,359,000				$ 2,000,000				1,359,000	$ 2,000,000
Acute Care EHR and TruBridge | Operating segments
Goodwill [Line Items]
Goodwill impairment									0
Post-acute Care EHR | Operating segments
Goodwill [Line Items]
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)									0		0
Goodwill impairment									0	28,000,000	0
Sales revenues:									22,192,000	24,033,000	26,519,000
Total costs of sales									$ 6,153,000	$ 7,481,000	$ 9,610,000
Forecast | ASU 2016-02
Goodwill [Line Items]
Operating lease, right-of-use asset												$ 4,900,000
Capital lease obligation												$ 4,900,000

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Changes in Deferred Revenue (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)
Accounting Policies [Abstract]
Balance as of January 1, 2018	$ 9,937
Deferred revenue recorded	19,818
Less deferred revenue recognized as revenue	(19,554)
Balance as of December 31, 2018	$ 10,201

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Changes in Capitalized Contract Cost (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)
Accounting Policies [Abstract]
Balance as of January 1, 2018	$ 3,775
Costs to obtain and fulfill contracts capitalized	3,345
Less costs to obtain and fulfill contracts recognized as expense	(4,103)
Balance as of December 31, 2018	$ 3,017

Disclosures of the impact of ad

Disclosures of the impact of adoption of Topic 606 (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 01, 2018
Income Statement [Abstract]
Sales revenues:	$ 72,327	$ 69,297	$ 67,905	$ 70,882	$ 78,062	$ 67,113	$ 67,677	$ 64,075	$ 280,411	$ 276,927	$ 267,272
System sales and support									75,984	80,018	87,882
Gross profit	39,684	36,113	34,846	39,085	44,202	34,380	35,991	32,700	149,728	147,273	133,734
Sales and marketing									30,713	33,021	27,194
Operating income (loss)	9,648	5,361	2,225	7,648	(18,118)	5,622	4,448	3,234	24,882	(4,814)	14,375
Provision for income taxes									476	3,933	4,053
Net income (loss)	7,588	$ 5,749	$ 328	$ 3,967	(21,537)	$ 2,288	$ 1,587	$ 246	17,632	(17,416)	3,933
Statement of Financial Position [Abstract]
Prepaid expenses and other	5,055				2,824				5,055	2,824
Other assets, net of current portion	995				0				995	0
Total assets	327,746				318,216				327,746	318,216
Deferred revenue	10,201				8,707				10,201	8,707
Deferred tax liabilities	4,877				4,667				4,877	4,667
Total liabilities	167,963				182,130				167,963	182,130
Accumulated deficit	(5,024)				(19,006)				(5,024)	(19,006)
Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Income Statement [Abstract]
System sales and support									75,857
Gross profit									149,872
Sales and marketing									30,083
Operating income (loss)									25,656
Provision for income taxes									638
Net income (loss)									18,244
Statement of Financial Position [Abstract]
Prepaid expenses and other	3,032								3,032
Other assets, net of current portion	0								0
Total assets	324,728								324,728
Deferred revenue	8,953								8,953
Deferred tax liabilities	4,466								4,466
Total liabilities	166,304								166,304
Accumulated deficit	(6,383)								(6,383)
ASU 2014-09 | Difference between revenue guidance in effect before and after Topic 606
Income Statement [Abstract]
Sales revenues:										1,600
System sales and support									127
Gross profit									(144)
Sales and marketing									630
Operating income (loss)									(774)
Provision for income taxes									(162)
Net income (loss)									(612)
Statement of Financial Position [Abstract]
Prepaid expenses and other	2,023								2,023
Other assets, net of current portion	995								995
Total assets	3,018								3,018
Deferred revenue	1,248								1,248
Deferred tax liabilities	411								411			$ 600
Total liabilities	1,659								1,659
Accumulated deficit	$ 1,359				$ 2,000				1,359	2,000
Service [Member]
Income Statement [Abstract]
Sales revenues:									100,247	$ 88,666	$ 81,607
Service [Member] | Calculated under Revenue Guidance in Effect before Topic 606 [Member]
Income Statement [Abstract]
Sales revenues:									100,264
Service [Member] | ASU 2014-09 | Difference between revenue guidance in effect before and after Topic 606
Income Statement [Abstract]
Sales revenues:									$ (17)

Business Combination - Narrativ

Business Combination - Narrative (Details) - USD ($) $ in Thousands	Jan. 08, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Business Acquisition [Line Items]
Acquisition related costs		$ 0
Healthland Holding, Inc.
Business Acquisition [Line Items]
Cash consideration, net of acquired cash received	$ 162,611
Number of stock options transferred (in shares)	1,973,880
Number of common shares transferred (in shares)	174,972
Goodwill expected to be tax deductible	$ 23,300
Gross contractual amount of accounts receivable	$ 9,400
Acquisition related costs, net of severance costs			$ 5,500
Severance costs			2,700
Healthland Holding, Inc. | General and administrative expenses
Business Acquisition [Line Items]
Acquisition related costs			$ 8,200	$ 3,000

Business Combination - Allocati

Business Combination - Allocation of Purchase Price (Details) - USD ($) $ in Thousands	Jan. 08, 2016	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Business Acquisition [Line Items]
Goodwill		$ 140,449	$ 140,449	$ 168,449	$ 0
Contingent consideration		$ (206)	$ (586)
Healthland Holding, Inc.
Business Acquisition [Line Items]
Cash consideration, net of acquired cash received	$ 162,611
Fair value of common stock and options issued as consideration	97,017
Total consideration	259,628
Acquired cash	5,371
Accounts receivable	5,789
Financing receivables	2,184
Inventories	216
Prepaid expenses	3,228
Property and equipment	1,263
Intangible assets	117,300
Goodwill	168,449
Accounts payable and accrued liabilities	(17,490)
Deferred taxes, net	(4,010)
Contingent consideration	(1,620)
Deferred revenue	(15,681)
Net assets acquired	$ 264,999

Business Combination - Pro Form

Business Combination - Pro Forma Results of Income (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2016USD ($)$ / shares
Business Acquisition [Line Items]
Pro forma revenues	$ 270,974
Pro forma net income	$ 8,538
Pro forma diluted earnings per share (in dollars per share) | $ / shares	$ 0.64

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 16,520	$ 21,866
Less: accumulated depreciation	(5,645)	(10,174)
Property and equipment, net	10,875	11,692
Land
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,848	2,848
Buildings and improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	7,752	8,240
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,766	3,245
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,198	5,001
Office furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,938	2,462
Automobiles
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 18	$ 70

Other Accrued Liabilities (Deta

Other Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Payables and Accruals [Abstract]
Salaries and benefits	$ 8,722	$ 8,432
Severance	992	1,139
Commissions	830	2,416
Self-insurance reserves	1,017	1,024
Contingent consideration	206	586
Other	452	501
Other accrued liabilities	$ 12,219	$ 14,098

Net Income Per Share (Details)

Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Numerator
Net income (loss)	$ 7,588	$ 5,749	$ 328	$ 3,967	$ (21,537)	$ 2,288	$ 1,587	$ 246	$ 17,632	$ (17,416)	$ 3,933
Less: Net (income) loss attributable to participating securities									(595)	316	(38)
Net income (loss) attributable to common stockholders									$ 17,037	$ (17,100)	$ 3,895
Denominator
Weighted average shares outstanding used in basic per common share computations (in shares)									13,561	13,419	13,255
Basic EPS (in dollars per share)	$ 0.54	$ 0.41	$ 0.02	$ 0.29	$ (1.57)	$ 0.17	$ 0.11	$ 0.02	$ 1.26	$ (1.27)	$ 0.29
Numerator
Net income (loss) attributable to common stockholders									$ 17,037	$ (17,100)	$ 3,895
Reallocation of net income (loss) attributable to participating securities									0	0	0
Net income (loss) attributable to common stockholders for diluted EPS									$ 17,037	$ (17,100)	$ 3,895
Denominator
Weighted average shares outstanding used in basic per common share computations (in shares)									13,561	13,419	13,255
Weighted average effect of dilutive securities:
Performance share awards (in shares)									7	0	0
Weighted average shares outstanding used in diluted per common share computations (in shares)									13,568	13,419	13,255
Diluted EPS (in dollars per share)	$ 0.54	$ 0.41	$ 0.02	$ 0.29	$ (1.57)	$ 0.17	$ 0.11	$ 0.02	$ 1.26	$ (1.27)	$ 0.29

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)event	Dec. 31, 2016USD ($)	Dec. 31, 2015
Operating Loss Carryforwards [Line Items]
Re-measurement of net deferred tax liability, resulting in additional tax benefit		$ 1,900
U.S. federal statutory income tax rate	35.00%		35.00%	35.00%
Effective income tax rate	3.00%	(29.00%)	51.00%
Number of factors impacting net expense impact (in events) | event		3
Net income tax expense impact		$ 8,800
Impact to effective rate		65.00%
Permanent non-deductible acquisition transaction costs			$ 3,800
Valuation allowance	$ 456	$ 1,605
Domestic tax authority
Operating Loss Carryforwards [Line Items]
Federal net operating loss carryforward	40,500	53,900	70,500
State jurisdiction
Operating Loss Carryforwards [Line Items]
Federal net operating loss carryforward	$ 34,500	$ 37,100	$ 46,500

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Deferred tax assets:
Accounts receivable and financing receivables	$ 1,112	$ 1,395
Accrued vacation	529	519
Stock-based compensation	2,264	1,416
Deferred revenue	250	132
Accrued severance	173	207
Accrued liabilities and other	0	884
Fixed assets	0	172
Credits	1,984	0
Net operating loss	10,347	13,261
Deferred tax assets	16,659	17,986
Less: Valuation allowance	456	1,605
Total deferred tax assets	16,203	16,381
Deferred tax liabilities:
Intangible assets	19,957	21,048
Accrued liabilities and other	897	0
Fixed assets	226	0
Total deferred tax liabilities	21,080	21,048
Total net deferred tax liability	$ (4,877)	$ (4,667)

Income Taxes - Significant Comp

Income Taxes - Significant Components of Income Tax Provision (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Current provision:
Federal	$ (594)	$ 1,535	$ (72)
State	1,434	977	453
Deferred provision:
Federal	649	1,070	4,144
State	(1,013)	351	(472)
Total income tax provision	$ 476	$ 3,933	$ 4,053

Income Taxes - Reconciliation t

Income Taxes - Reconciliation to Federal Statutory Income Tax Rate (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Income taxes at U.S. federal statutory rate	$ 3,803	$ (4,584)	$ 2,795
Provision-to-return adjustments	(112)	433	325
State income tax, net of federal tax effect	1,109	458	5
Domestic production activities deduction	0	(280)	0
Tax credits	(3,428)	(393)	(349)
Transaction costs	0	0	1,312
Goodwill impairment	0	9,520	0
Stock-based compensation	356	1,155	0
Deferred impact of tax reform	0	(1,890)	0
Change in valuation allowance	(1,149)	(304)	0
Other	(103)	(182)	(35)
Total income tax provision	$ 476	$ 3,933	$ 4,053

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future issuance (in shares) | shares	324,257
Unrecognized compensation cost related to non-vested share-based compensation | $	$ 12.9
Unrecognized compensation cost related to non-vested share-based compensation period of recognition	1 year 10 months 24 days
Performance shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	1 year
Performance shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years

Stock-Based Compensation - Tota

Stock-Based Compensation - Total Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Pre-tax stock-based compensation expense	$ 9,715	$ 7,166	$ 5,366
Less: income tax effect	(2,040)	(2,795)	(2,093)
Net (after tax) stock-based compensation expense	7,675	4,371	3,273
Costs of sales
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Pre-tax stock-based compensation expense	2,134	1,750	1,396
Operating expenses
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Pre-tax stock-based compensation expense	$ 7,581	$ 5,416	$ 3,970

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Activity Under Restricted and Performance Stock Plans (Details) - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Restricted stock
Shares
Outstanding at beginning of period (in shares)	309,195	184,885	191,397
Granted (in shares)	148,841	225,954	86,984
Performance share awards converted to restricted stock	177,395
Vested (in shares)	(156,988)	(101,644)	(93,496)
Forfeited (in shares)	(3,311)
Outstanding at end of period (in shares)	475,132	309,195	184,885
Weighted-Average Grant-Date Fair Value
Outstanding at beginning of the period (in dollars per share)	$ 38.36	$ 54.63	$ 57.12
Granted (in dollars per share)	30.20	32.79	52.21
Performance share awards converted to restricted stock (in dollars per share)	29.94
Vested (in dollars per share)	40.52	55.58	57.48
Forfeited (in dollars per share)	30.20
Outstanding at end of the period in dollars per share)	$ 32	$ 38.36	$ 54.63
Performance shares
Shares
Outstanding at beginning of period (in shares)	189,325	77,594	49,471
Granted (in shares)	184,776	189,325	77,594
Performance share awards converted to restricted stock	(177,395)
Forfeited (in shares)	(11,930)	(77,594)	(49,471)
Outstanding at end of period (in shares)	184,776	189,325	77,594
Weighted-Average Grant-Date Fair Value
Outstanding at beginning of the period (in dollars per share)	$ 29.94	$ 49.64	$ 49.29
Granted (in dollars per share)	30.15	29.94	49.64
Performance share awards converted to restricted stock (in dollars per share)	29.94
Forfeited (in dollars per share)	29.94	49.64	49.29
Outstanding at end of the period in dollars per share)	$ 30.15	$ 29.94	$ 49.64

Financing Receivables - Narrati

Financing Receivables - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Receivables [Abstract]
Total financing receivables	$ 34,322	$ 26,540
Increase in amounts considered past due	$ 600

Financing Receivables - Short-T

Financing Receivables - Short-Term Payment Plans (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Accounts, Notes, Loans and Financing Receivable [Line Items]
Short-term payment plans, net	$ 15,059	$ 15,055
Short-term payment plans, gross
Accounts, Notes, Loans and Financing Receivable [Line Items]
Short-term payment plans, gross	5,773	9,081
Less: allowance for losses	(404)	(638)
Short-term payment plans, net	$ 5,369	$ 8,443

Financing Receivables - Compone

Financing Receivables - Components of Lease Receivables (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Receivables [Abstract]
Sales-type leases, gross	$ 34,841	$ 22,968
Less: allowance for losses	(2,163)	(2,606)
Less: unearned income	(3,725)	(2,265)
Sales-type leases, net	$ 28,953	$ 18,097

Financing Receivables - Future

Financing Receivables - Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Receivables [Abstract]
2019	$ 10,825
2020	9,098
2021	6,942
2022	4,792
2023	2,423
Thereafter	761
Total minimum lease payments to be received	34,841
Less: allowance for losses	(2,163)	$ (2,606)
Less unearned income	(3,725)	$ (2,265)
Net lease receivables	$ 28,953

Financing Receivables - Allowan

Financing Receivables - Allowance for Financing Credit Losses (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Allowance for Doubtful Accounts Receivable [Roll Forward]
Beginning Balance	$ 3,244	$ 2,198
Provision	1,691	1,823
Charge-offs	(2,368)	(777)
Recoveries	0	0
Ending Balance	$ 2,567	$ 3,244

Financing Receivables - Analysi

Financing Receivables - Analysis of Age of Financing Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Receivables [Abstract]
1 to 90 Days Past Due	$ 1,302	$ 980
91 to 180 Days Past Due	210	171
181 Days Past Due	245	0
Total Past Due	$ 1,757	$ 1,151

Financing Receivables - Summary

Financing Receivables - Summary of Financing Receivables by Credit Quality Indicator (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Customer balances with amounts reclassified to trade accounts receivable that are:
1 to 90 Days Past Due	$ 17,290	$ 11,300
91 to 180 Days Past Due	2,247	3,727
181 Days Past Due	885	967
Total uninvoiced customer financing receivables balances of customers with a trade accounts receivable	20,422	15,994
Total uninvoiced customer financing receivables of customers with no related trade accounts receivable	10,694	4,709
Total financing receivables with contractual maturities of one year or less	5,773	9,081
Less allowance for losses	(2,567)	(3,244)	$ (2,198)
Total financing receivables	$ 34,322	$ 26,540

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		$ 117,300
Accumulated amortization	$ (10,487)	(20,587)
Net intangible assets	$ 86,226	96,713
Weighted average remaining years of useful life	9 years
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		82,300
Accumulated amortization	$ (6,539)	(12,937)
Net intangible assets	$ 62,824	69,363
Weighted average remaining years of useful life	10 years
Trademark
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		10,900
Accumulated amortization	$ (931)	(1,682)
Net intangible assets	$ 8,287	9,218
Weighted average remaining years of useful life	12 years
Developed Technology
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount		24,100
Accumulated amortization	$ (3,017)	(5,968)
Net intangible assets	$ 15,115	$ 18,132
Weighted average remaining years of useful life	5 years

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Amortization (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
2019	$ 10,072
2020	10,066
2021	10,066
2022	10,066
2023	10,066
Due thereafter	35,890
Net intangible assets	$ 86,226	$ 96,713

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Schedule of Goodwill (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 140,449,000	$ 168,449,000	$ 0
Goodwill acquired			168,449,000
Goodwill impairment	0	(28,000,000)	0
Goodwill, ending balance	140,449,000	140,449,000	168,449,000
Operating segments | Acute Care EHR
Goodwill [Roll Forward]
Goodwill, beginning balance		97,095,000	0
Goodwill acquired			97,095,000
Goodwill impairment		0
Goodwill, ending balance	97,095,000		97,095,000
Operating segments | Post-acute Care EHR
Goodwill [Roll Forward]
Goodwill, beginning balance		57,570,000	0
Goodwill acquired			57,570,000
Goodwill impairment	0	(28,000,000)	0
Goodwill, ending balance	29,570,000		57,570,000
Operating segments | TruBridge
Goodwill [Roll Forward]
Goodwill, beginning balance		13,784,000	0
Goodwill acquired			13,784,000
Goodwill impairment		$ 0
Goodwill, ending balance	$ 13,784,000		$ 13,784,000

Long-Term Debt - Schedule of De

Long-Term Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Capital lease obligation	$ 250	$ 565
Less: debt issuance costs	(1,306)	(1,652)
Debt obligation, net	131,069	142,434
Less: current portion	(6,486)	(5,820)
Long-term debt	124,583	136,614
Line of credit
Debt Instrument [Line Items]
Debt obligations	132,375	144,086
Debt obligation, net	132,375
Line of credit | Term loan facility
Debt Instrument [Line Items]
Debt obligations	102,432	115,538
Line of credit | Revolving credit facility
Debt Instrument [Line Items]
Debt obligations	$ 29,693	$ 27,983

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details)

1 Months Ended

3 Months Ended

12 Months Ended

21 Months Ended

24 Months Ended

Jan. 31, 2016USD ($)

Mar. 31, 2018USD ($)

Dec. 31, 2017

Sep. 30, 2022USD ($)

Dec. 31, 2017

Sep. 30, 2019USD ($)

Sep. 30, 2017

Sep. 30, 2021USD ($)

Dec. 31, 2018USD ($)

Feb. 08, 2018USD ($)

Feb. 07, 2018USD ($)

Oct. 13, 2017USD ($)

Debt Instrument [Line Items]

Amount of credit facility

$ 167,000,000

$ 162,000,000

Current borrowing capacity

$ 162,000,000

175,000,000

Early repayments of lines of credit

$ 7,300,000

Line of credit

Debt Instrument [Line Items]

Line of credit facility, incremental facility capacity

50,000,000

Minimum fixed charge coverage ratio

1.25

Maximum consolidated leverage ratio

3.95

3.50

Line of credit facility, capacity available for dividends

$ 18,300,000

Prepayment percentage of excess cash flow in 2017 and 2018

75.00%

Prepayment amount from excess cash flow

50.00%

Line of credit | Term loan facility

Debt Instrument [Line Items]

Amount of credit facility

$ 125,000,000

117,000,000

117,000,000

Line of credit | Term loan facility | Forecast

Debt Instrument [Line Items]

Quarterly principal payments

$ 2,930,000

$ 1,460,000

$ 2,190,000

Line of credit | Revolving credit facility

Debt Instrument [Line Items]

Amount of credit facility

$ 50,000,000

$ 50,000,000

$ 45,000,000

Line of credit | Revolving credit facility | Federal funds rate

Debt Instrument [Line Items]

Basis spread on variable rate

0.50%

0.50%

Line of credit | Revolving credit facility | LIBOR rate | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

2.00%

Line of credit | Revolving credit facility | LIBOR rate | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

3.50%

Line of credit | Revolving credit facility | Base rate | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate

1.00%

Line of credit | Revolving credit facility | Base rate | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate

2.50%

Long-Term Debt - Anticipated An

Long-Term Debt - Anticipated Annual Future Maturities (Details) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Debt obligation, net	$ 131,069	$ 142,434
Line of credit
Debt Instrument [Line Items]
2019	6,831
2020	8,775
2021	9,506
2021	107,263
Thereafter	0
Debt obligation, net	$ 132,375

Benefit Plans (Details)

Benefit Plans (Details) - CPSI 401(k) Retirement Plan - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Jan. 31, 1994	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Defined Contribution Plan Disclosure [Line Items]
Requisite service period for employee eligibility	1 year
Employee contribution (up to)			60.00%
Employer contribution		$ 2.6	$ 2.6	$ 2.8

Operating Leases - Narrative (D

Operating Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Leases [Abstract]
Total rent expense	$ 2.6	$ 2.6	$ 2.7

Operating Leases - Future Minim

Operating Leases - Future Minimum Lease Payments (Details) $ in Thousands	Dec. 31, 2018USD ($)
Leases, Operating [Abstract]
2019	$ 1,482
2020	997
2021	960
2022	887
2023	844
Thereafter	2,515
Total future minimum lease payments payable under operating leases	$ 7,685

Fair Value (Details)

Fair Value (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment of earnout incentive	$ 409	$ 625	$ 500
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	206	586
Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	0	0
Fair Value | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	0	0
Fair Value | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration	206	$ 586
Former Rycan shareholders
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment of earnout incentive	$ 409

Segment Reporting (Details)

Segment Reporting (Details) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2018USD ($)	Mar. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Sep. 30, 2017USD ($)	Jun. 30, 2017USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2018USD ($)segment	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment									3
Sales revenues:	$ 72,327	$ 69,297	$ 67,905	$ 70,882	$ 78,062	$ 67,113	$ 67,677	$ 64,075	$ 280,411	$ 276,927	$ 267,272
Total cost of sales									130,683	129,654	133,538
Gross profit	$ 39,684	$ 36,113	$ 34,846	$ 39,085	$ 44,202	$ 34,380	$ 35,991	$ 32,700	149,728	147,273	133,734
Corporate operating expenses									(124,846)	(152,087)	(119,359)
Other income									803	407	220
Loss on extinguishment of debt									0	(1,340)	0
Interest expense									(7,577)	(7,736)	(6,609)
Income (loss) before taxes									18,108	(13,483)	7,986
Operating segments | Acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:									157,972	164,228	159,146
Total cost of sales									69,831	72,537	78,272
Gross profit									88,141	91,691	80,874
Operating segments | Post-acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:									22,192	24,033	26,519
Total cost of sales									6,153	7,481	9,610
Gross profit									16,039	16,552	16,909
Operating segments | TruBridge
Segment Reporting Information [Line Items]
Sales revenues:									100,247	88,666	81,607
Total cost of sales									54,699	49,636	45,656
Gross profit									45,548	39,030	35,951
Corporate
Segment Reporting Information [Line Items]
Corporate operating expenses									(124,846)	(152,087)	(119,359)
Recurring revenue | Operating segments | Acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:									111,936	113,056	117,482
Recurring revenue | Operating segments | Post-acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:									18,599	20,122	20,082
Non-recurring revenue | Operating segments | Acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:									46,036	51,172	41,664
Non-recurring revenue | Operating segments | Post-acute Care EHR
Segment Reporting Information [Line Items]
Sales revenues:									$ 3,593	$ 3,911	$ 6,437

Subsequent Events (Details)

Subsequent Events (Details)	Feb. 15, 2019$ / shares
Subsequent event
Subsequent Event [Line Items]
Per share dividend announced by the company (in dollars per share)	$ 0.10

Quarterly Financial Statement_3

Quarterly Financial Statements (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]
Sales revenues:	$ 72,327	$ 69,297	$ 67,905	$ 70,882	$ 78,062	$ 67,113	$ 67,677	$ 64,075	$ 280,411	$ 276,927	$ 267,272
Gross profit	39,684	36,113	34,846	39,085	44,202	34,380	35,991	32,700	149,728	147,273	133,734
Operating income (loss)	9,648	5,361	2,225	7,648	(18,118)	5,622	4,448	3,234	24,882	(4,814)	14,375
Net income (loss)	$ 7,588	$ 5,749	$ 328	$ 3,967	$ (21,537)	$ 2,288	$ 1,587	$ 246	$ 17,632	$ (17,416)	$ 3,933
Net income (loss) per share
Net income (loss) per share - basic (in dollars per share)	$ 0.54	$ 0.41	$ 0.02	$ 0.29	$ (1.57)	$ 0.17	$ 0.11	$ 0.02	$ 1.26	$ (1.27)	$ 0.29
Net income (loss) per share - diluted (in dollars per share)	$ 0.54	$ 0.41	$ 0.02	$ 0.29	$ (1.57)	$ 0.17	$ 0.11	$ 0.02	$ 1.26	$ (1.27)	$ 0.29

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts - Allowance for Doubtful Accounts (Details) - Allowance for doubtful accounts deducted from accounts receivable in the balance sheet - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period		$ 2,654	$ 2,370	$ 1,216
Additions charged to cost and expenses	[1]	1,485	1,598	497
Deductions	[2]	(2,015)	(1,314)	657
Balance at end of period		$ 2,124	$ 2,654	$ 2,370
[1]	Adjustments to allowance for change in estimates.
[2]	Uncollectible accounts written off, net of recoveries.

Schedule II - Valuation and Q_3

Schedule II - Valuation and Qualifying Accounts - Allowance for Credit Losses (Details) - Allowance for credit losses deducted from financing receivables in the balance sheet - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period		$ 3,244	$ 2,198	$ 654
Additions charged to cost and expenses	[1]	1,691	1,823	1,762
Deductions	[2]	(2,368)	(777)	(218)
Balance at end of period		$ 2,567	$ 3,244	$ 2,198
[1]	Adjustments to allowance for change in estimates.
[2]	Uncollectible accounts written off, net of recoveries.

Uncategorized Items - cpsi-2018

Label	Element	Value
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 1,970,000
Retained Earnings [Member]
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	$ 1,970,000